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Abstract 
In recent years thousands of people have died due to illicit drug overdoses caused by 
increasingly powerful and contaminated substances offered through the illicit drug market 
(Corace et al., 2019). The current drug-related overdose crisis has presented an opportunity for 
drug policy changes throughout Canada. While the current government has made progressive 
changes to Canadian drug policy in recent years, further research on effective and efficient drug 
policy is warranted to combat the growing concerns related to the harms associated with drug use 
and substance addiction.  
This study furthers the understanding of how those who have experienced substance 
addiction view the current and past drug policies in Canada. This research also served to gain 
this population’s insight on the effective and ineffective drug strategies within the system and 
what approach would best prevent and treat substance addiction. To complete this research, 19 
qualitative one-on-one interviews were conducted with individuals who have experienced or are 
currently experiencing substance addiction.  
Several related themes emerged from the interviews, including findings that demonstrate 
the support among people who have had substance addiction for: the decriminalization of all 
illicit substances in Canada; a legalized safe supply of specific illicit substances; a rehabilitated 
and modern approach to treatment programs for substance addiction; and the reduction or 
elimination of stigmatization towards people who use drugs. The findings of this research add to 
the growing body of literature that considers the perspectives of those who are addicted to illicit 
substances – a population that is arguably the most affected by drug policy. 
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Chapter 1: Introduction 
For many, substance addiction is a reality. Either they have struggled with or succumbed 
to an addiction, or if not themselves, they have watched their mother, father, daughter, son, 
sister, brother, or friend battling in the trenches of drug use. Those who have experienced this 
reality live in fear. They fear they will say good-bye for the last time, or never get to say good-
bye at all. They fear their loved one will be imprisoned or will be killed. They fear for the 
damage their loved one may cause to others, or the damage they may cause to themselves. They 
fear that the latest hit will be the last. This fear is the reality.  
Approximately one in five people in Canada will experience substance addiction at some 
point in their lives (Hoskins, 2019). While substance addiction has always existed and varies in 
nature, there have been an increasing number of drug-related deaths in recent years – owing to an 
increase in contaminated illicit substances made available (Corace et al., 2019). Such deaths have 
brought the issue of addiction to the forefront of Canadian conversation. For example, the 
Canadian Government has made the opioid epidemic a leading public health and safety concern, 
and drug-related legislation and strategies have been reformed and implemented. However, as 
concerns related to the harms associated with drug use and substance addiction grow, the 
effectiveness and efficiency of these changes need to be examined and future drug policy reform 
needs to be considered.  
Addiction is a complex process in which problematic patterns of substance use or 
behaviours can interfere with a person’s life (Canadian Mental Health Association [CMHA], 
2019b). An addiction can be broadly defined as a condition that leads to compulsive and 
continuous engagement with a stimulus, regardless of negative consequences (CMHA, 2019b; 
Hartney, 2018). This can result in both physical and psychological dependence on particular 
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stimuli. Addictions can be either substance-related, such as the problematic use of alcohol or 
cocaine, or process-related, which includes gambling and internet additions (CMHA, 2019b). 
While both substance-related and process-related addictions can disrupt an individual’s ability to 
maintain a healthy lifestyle, this research specifically focuses on substance addiction.  
Substance addictions under the Diagnostic and Statistical Manual of Mental Disorders, 
Fifth Edition (DSM-V) are referred to as substance-related disorders; however, for the purposes 
of this research, the term substance addiction will be used as it a colloquial term used in Canada 
(CMHA, 2019b). The DSM-V is based on decades of research and clinical knowledge that 
recognizes that substance addictions can result from the use of various drugs, such as: alcohol; 
cannabis; hallucinogens; inhalants; opioids; sedatives, hypnotics, or anxiolytics; stimulants; 
tobacco; and other or unknown substances (Hartney, 2018).  
The DSM-V also recognizes that not all individuals are equally vulnerable to developing 
substance addictions, as some individuals are predisposed to a greater likelihood of developing 
an addiction (Hartney, 2018). Likewise, these substances vary in their potential to be addictive, 
yet this has little to do with their legal status. For example, tobacco is legal, but it is one of the 
most addictive drugs on the list. Lastly, this disorder varies in nature and can range from mild to 
severe depending on specific individual symptoms (CMHA, 2019b; Hartney, 2018).  
In its international drug report, the United Nations Office on Drugs and Crime (UNODC; 
2018) reported that approximately 275 million people worldwide, which is roughly 5.6% of the 
global population aged 15 to 64, used illicit drugs at least once during 2016. Of those, 31 million 
suffered from a substance addiction. Further, the report indicated that approximately 450,000 
people died as a result of drug use in 2015, and of those deaths, 167,750 were directly associated 
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with substance addictions. The report also noted that opioids accounted for 76% of all substance 
addiction related deaths (UNODC, 2018).  
In Canada, while drug trafficking and production have increased in recent years, the 
overall use of illicit drugs across all age groups has slightly declined (Canadian Centre for 
Addictions, 2019). Further, from its 2012 Canadian Community Health Survey, Statistics Canada 
(2015) found that lifetime rates of substance addiction accounted for 21.6% of the sample. The 
abuse or dependence of alcohol (18.1%), cannabis (6.8%), and other substances (4.0%) 
accounted for the total lifetime rates of substance addiction in this survey (Statistics Canada, 
2015). Thus, it can be inferred that only a small proportion of the Canadian population exhibits 
substance addictions to illicit drugs, as both alcohol and cannabis are legal in Canada. Despite 
this, there has been a growing illicit drug overdose epidemic in Canada in recent decades.  
Drug overdoses and drug overdose-related deaths have increased substantially in North 
America since 2000, especially within the past several years (Fischer, Vojtila, & Rehm, 2018; 
Rudd, Aleshire, Zibbell, & Gladden, 2016; Rudd, Seth, David & Scholl, 2016). In Canada, 
unintentional drug overdoses have become a public health crisis (Karamouzian, Kuo, Crabtree, 
& Buxton, in press). The increase in overdoses and drug-related deaths has been linked to the 
rise in fentanyl and its analogues within the illicit drug market (Corace et al., 2019).1 
Additionally, several other factors have been noted as contributors to the current opioid crisis, 
including: opioids being prescribed for pain relief; a lack of access to non-pharmacological 
treatments for pain; a lack of access to evidence-based treatment for opioid use disorder; silos 
between the mental health and substance use systems; and the stigmatization of people who use 
drugs (Corace et al., 2019). 
                                                 
1 Fentanyl is synthetic opioid that is similar to morphine but is 50 to 100 times more potent (National Institute on 
Drug Abuse, 2019, para. 1).  
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In 2017, there were almost 4,000 opioid-related deaths in Canada, 1,482 which occurred 
in British Columbia (BC; Government of Canada, 2018c). Another Canadian report noted that 
between January 2016 and June 2019, there were more than 13,900 suspected opioid-related 
deaths (Government of Canada, 2019b). Reported opioid-related hospitalizations occurred more 
frequently, with 17,050 between January 2016 and March 2019 (Government of Canada, 2019b). 
Further, in BC, the proportion of illicit drug overdose deaths with detected fentanyl increased 
from 4% in 2012 to more than 80% in 2017 and 2018 (BC Coroners Service, 2019). Given that 
BC has been the epicentre of the current drug-related overdose crisis in Canada, in April 2016, 
BC’s Provincial Medical Health Officer declared a public health emergency (BC Centre for 
Disease Control, 2017). This drug-related overdose crisis has presented an opportunity for drug 
policy changes throughout Canada.  
Historically, Canadian drug policy has been largely based on social and political factors, 
rather than on scientific research and ‘evidence-based’ practices (Malleck, 2015).2 This led to 
over a century of prohibitionist policy that resulted in an array of adverse outcomes, including 
high drug overdose rates, high rates of infectious diseases caused by needle-sharing, high rates of 
incarceration for drug offences, expensive law enforcement costs, and no significant reductions 
in drug use (Hathaway & Tousaw, 2008). However, the current Canadian Prime Minister (PM) 
Justin Trudeau and the Liberal Party of Canada have been taking steps since 2015 to reform 
Canadian drug policy and legislation. To date, they have implemented several progressive 
policies on drug possession and use, including legalizing cannabis in 2018 (Department of 
Justice, 2018).  
                                                 
2 Evidence-based policy is based on scrutiny and assessment of existing research, and the measurement of 
information about a program or treatment and its subsequent effectiveness (Valentine, 2009). 
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Moreover, this government has increased its efforts towards researching and 
implementing evidence-based drug strategies. In particular, the Federal Government has 
supported the implementation of several harm reduction initiatives across the country. These 
harm reduction initiatives include: naloxone programs; needle-exchange programs; and 
supervised injection facilities (SIFs), supervised consumption facilities (SCFs), and overdose 
prevention sites (OPSs; Government of Canada, 2018b).  
Irvine et al. (2019) conducted a study in BC to determine the combined effect of large-
scale opioid overdose preventions implemented in BC between April 2016 and December 2017 
on the number of deaths averted. They considered the effects of take-home naloxone kits, SCFs, 
OPSs, and opioid agonist therapy. Irvine et al. (2019) found that between 2900 and 3240 deaths 
were averted in BC by all interventions combined, with approximately 1580 averted by take-
home naloxone kits, 230 by OPSs, and 590 by opioid agonist therapy.   
While these initiatives have been effective in reducing various drug-related harms, 
including fatal overdoses, the rate of drug-related overdose deaths have continued to increase 
each year (Government of Canada, 2018c; Irvine et al., 2019; Kennedy et al., 2019). 
Additionally, some have argued that while drugs remain illegal, those who use drugs will 
continue to be marginalized from society and further criminalized, which decreases the overall 
effectiveness of the harm reduction strategies (van der Meulen, De Shalit & Ka Hon Chu, 2018; 
Lavalley, Kastor, Valleriani, & McNeil, 2018). These arguments and the ongoing drug-related 
deaths have fuelled support for increasingly liberal drug policy in Canada, including discussions 
on decriminalizing all illicit drugs and providing safe supplies for those who use opioids (Angus 
Reid Institute, 2019; Corace et al., 2019). Therefore, while the current government has made 
progressive changes to Canadian drug policy in recent years, it is clear that further research on 
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effective and efficient drug policy is necessary to combat the growing concerns related to the 
harms associated with drug use and substance addiction.  
To aid in informing future drug policy changes in Canada, several key groups of 
stakeholders should be involved. In particular, the perceptions of people who have experienced 
addiction should be considered when developing and implementing drug policy. This includes 
recognizing the lived experiences of those who use drugs and considering their opinions on the 
current legislation and subsequent strategies employed by the government to reduce the use of 
drugs, decrease the harms associated with drug use, and prevent and treat substance addiction.  
This research was designed to further the understanding of how those who have 
experienced substance addiction view the current and past drug policies in Canada. It explores 
what this population believes are effective and ineffective drug strategies within the system and 
what approach may be best in preventing and treating substance addiction. The findings of this 
research add to the growing body of literature that considers the perspectives of those who are 
addicted to illicit substances – a population that is arguably the most affected by drug policy. 
There are several objectives of the current study. First, it examines how the current state 
of Canadian drug policy affects the various perceptions of those who have experienced or are 
currently experiencing substance addiction. Second, the study explores the history of Canadian 
drug policy and its impact on individuals with substance addictions. Third, this research strives 
to understand the consequences of government mandate changes on drug policy on those who are 
struggling with substance addictions. Fourth, the project analyzes the perceived effects of 
punitive versus rehabilitative approaches to preventing and treating substance addictions. Lastly, 
the project investigates potential options for future drug policy changes that are supported by 
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those who have experienced or are currently experiencing substance addictions. From these 
objectives, several themes emerged from the analyzed data, which will later be explored.  
  
 8 
Chapter 2: General Problem – The Stigmatization of Drug Use 
There is a small but growing body of literature that has examined how individuals who 
use illicit drugs view current drug policy (Darke & Torok, 2013; Lancaster, Ritter, & Stafford, 
2013; Lancaster, Santana, Madden, & Ritter, 2015; Lancaster, Sutherland, & Ritter, 2014). These 
studies have been recognized as an important step towards considering and incorporating the 
views of those who use drugs in drug policy analysis, since a majority of public opinion research 
on drug policy has focused on the perceptions of the general public (Lancaster et al., 2015). 
Lancaster et al. (2013) contended that policy should be informed by those who use drugs – the 
individuals it most directly affects. Similarly, Montagne (2002) concluded that there is a need for 
Canadian research that focuses on the perceptions and experiences of people who use drugs.  
Unfortunately, the voices of those who use drugs have often been excluded from drug 
policy debate – in Canada and worldwide (Lancaster et al., 2013). This has resulted in policy and 
practices that have excluded the opinions and lived experiences of the specific community it 
affects (Tutenges, Kolind, & Uhl, 2015). The lack of research on the perceptions of drug using 
groups is reflected in the policy, prevention, and treatment interventions implemented and has 
resulted in various ineffective and inefficient drug strategies.  
However, critics have argued that individuals who use drugs are too delusional, 
disorganized, or biased to provide useful information about their own lived experiences. As such, 
they have argued that this population should be excluded from contributing to drug policy 
decisions (Tutenges et al., 2015). Regardless of these critical assertions, drug policy should be 
informed by those who use drugs, since giving this population a voice can better inform policy 
development and decisions, build trust between this population and the government, and increase 
the legitimacy of the strategies implemented (Lancaster et al., 2013). Thus, despite the belief 
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among some individuals that drug policy should not be informed by those who use drugs, there is 
value in considering and incorporating this population’s knowledge and lived experiences into 
future policy decisions.  
Stigmatization and Labelling: Reviewing Goffman, Lemert, and Braithwaite 
There are many theories that relate to crime and deviance; however, this analysis will 
focus on specific theories that aid in explaining how negative societal perceptions of drug using 
groups affect this population. This negative societal response ultimately lends support to 
excluding their involvement in policy development. Erving Goffman’s (1963) theory of 
stigmatization outlined the idea of stigma and the plight of those who are stigmatized. He argued 
that stigmatized individuals are those that are not fully accepted by society and who are 
constantly striving to adjust their social identities.  
Goffman (1963) identified three types of stigma: physical stigma; stigma of group 
identity; and stigma of character traits. Physical stigma refers to physical deformities of the body, 
while stigma of group identity refers to stigma that is caused by being a part of a particular race, 
nation, or religion. Goffman (1963) explained that stigma of character traits are:  
…blemishes of individual character perceived as weak will, domineering or unnatural 
passions, treacherous and rigid beliefs, and dishonesty, these being inferred from a 
known record of, for example, mental disorder, imprisonment, addiction, alcoholism, 
homosexuality, unemployment, suicidal attempts, and radical political behaviour. (p. 14) 
 
Goffman (1963) also argued that the three types of stigma are similar in that they share the same 
sociological features – an individual who may have been accepted within normal social 
interactions “possesses a trait that can obtrude itself upon attention”, which results in a negative 
societal reaction and subsequent labelling (p. 15). In other words, an individual who possesses 
stigma has an undesired differentness from what ‘normal’ society expects – making that 
individual an outcast or an ‘other’ in that particular society.  
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Goffman (1963) argued that stigma theory is constructed as a way to explain the 
inferiority of the stigmatized individual, to account for their dangerousness, and to rationalize an 
animosity based on other differences, such as social class. He suggested that those without 
stigma, or ‘normals’, believe that an individual with a stigma is not quite human. Consequently, 
he maintained that ‘normals’ exercise multiple forms of discrimination against the stigmatized 
individual, which effectively reduces their quality of life.  
The discrimination against stigmatized individuals leads them to question how others will 
identify and receive them. He contended that the stigmatized individual’s awareness of 
inferiority leads to self-consciousness, feelings of insecurity, anxiety, and sometimes jealousy 
(Goffman, 1963). This is referred to as internalized stigma, which is when a stigmatized 
individual cognitively or emotionally internalizes the negative messages or stereotypes that the 
greater society places on him or her. Goffman (1963) also asserted that those with similar 
stigmas, such as alcoholics, sex workers, or people who use drugs, will form small social groups, 
in which the members of the group all derive from the specific stigmatized category. The 
individuals who share a particular stigma and social group will subsequently rely on each other 
for mutual aid or support (Goffman, 1963).  
Goffman (1963) explained that there are many signs that can convey social information, 
and the nature of this information can lead to prestige or to stigmatization. For example, the 
symbols, or signs, of stigma on an individual can include the scars from an attempted suicide, 
pock marks or sores from drug use, or the handcuffed wrists of an offender in transit. He argued 
that due to the visibility of many stigmas, the stigmatized individual will make efforts to conceal 
their stigma, or to adapt or conform their identity in an effort to be perceived as normal. This 
allows for some individuals to function with a stigma, while others are outcasted. However, 
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Goffman (1963) highlighted that there are some individuals, such as sex workers, thieves, and 
people who use drugs, who must conceal their stigma from one class of persons, such as the 
police, while simultaneously exposing themselves to other classes of persons, such as clients, 
fellow-members, and drug dealers. Ultimately, an individual’s social identity can affect how they 
are perceived by others.  
Goffman (1963) argued that the term ‘deviance’ represents the actions of social deviants, 
a group of stigmatized individuals that consists of sex workers, people who use drugs, 
delinquents, criminals, jazz musicians, carnival workers, homeless persons, gypsies, alcoholics, 
show people, full-time gamblers, beach dwellers, and the urban unrepentant poor. He maintained 
that these individuals are perceived as: failing to use available opportunity for advancement; 
openly showing disrespect for their superiors; lacking piety; and, representing failures in the 
motivational schemes of society. Consequently, he affirmed that social deviants collectively 
deny the social order of normal society. Ultimately, Goffman’s (1963) theory of stigmatization 
concluded that stigmatized individuals are those who are not fully accepted by society, which 
leads to various forms of discrimination. 
Comparatively, Edwin Lemert (1951) hypothesized the notion of primary and secondary 
deviance. Lemert (1951) argued that the socially visible deviations within a group, community, 
or society creates a reaction among the whole of the group, community, or society – the nature 
and severity of the reaction and attitude towards this deviation would depend upon the 
expectations of the conforming majority. The severity of the societal reaction will depend on the 
compulsory nature of the norm being violated or deviated from. He explained that the societal 
reaction will affect the intensity, degree, amount, and visibility of the deviation.  
 12 
According to Lemert (1951), primary deviance refers to behaviour that does not abide by 
a social norm yet causes no long-term consequences for the wrongdoer. He noted that the 
absence of long-term consequences may be due to the fact that the initial deviance prompted no 
reaction, or that the reaction to the deviance was not particularly negative or stigmatizing. 
Consequently, primary deviance does not lead to a permanent label from peers, nor to a deviant 
or stigmatized self-identity.  
Lemert (1951) explained that recurring deviations and the formation of a deviant sub-
group will work to alter the culture and social organization of the community where the 
deviations occur. This leads to mythologies, stigma, stereotypes, patterns of exploitation, 
accommodation, segregation, and methods of control that formalize between the deviants and the 
rest of society. He suggested that the informal societal reactions are further extended by the 
formal processes of penalizing and restraining or reforming those who are perceived as deviant. 
This leads to the status of the individual being redefined as deviant. In this sense, secondary 
deviance arises when this status is placed on an individual – the permanent status among peers as 
an outcast.  
In essence, Lemert (1951) argued that not all violations of social norms result in long-
term negative consequences. Some acts, such as driving over the speed limit, may go undetected 
by law enforcement or other persons, and result in no consequences. In some cases, the act may 
be detected, and the perpetrator may be subject to a punishment that serves to deter that 
individual from further violations, such as being issued a fine for speeding. However, these 
violations are quickly forgotten, and the perpetrator will proceed with generally law-abiding 
behaviour. While primary deviance receives no social reaction or mild, corrective action, if 
deviant behaviour is repeated or persists, the societal reaction becomes stronger and increasingly 
 13 
punitive (Lemert, 1951). As previously noted, when the continued violations of social norms 
produce societal consequences strong enough to cause stigmatization, secondary deviance can 
result.  
Lemert (1951) explained that as the individual becomes increasingly reprimanded by 
society, the individual will begin to resent both the societal norms being violated and the social 
structures that are imposing the consequences. Eventually the individual will reach a level of 
resentment that results in the individual creating a self-concept that mirrors the definition of 
deviant as set by the group. He maintained that the most significant personality changes that 
occur at this stage manifest when societal definitions become generalized. As a result, the 
individual is left to define themselves by the greater society, without choice of an alternative 
role. However, Lemert (1951) also explained that an individual’s internal make-up and 
personality will affect their likelihood of accepting this deviant role, since not all individuals 
labelled deviant or criminal adopt a criminal role. Those who do accept the deviant social status 
will make efforts to adjust to their new role, leading to further deviant behaviour.  
Essentially, secondary deviance is more severe than primary deviance and results from an 
entrenched self- and social-identity. Those who display secondary deviance are also more likely 
to align themselves with others who have been similarly labelled – becoming part of a subculture 
that rejects the normative framework created by the original social group. In general, Lemert’s 
(1951) theory on primary and secondary deviance sought to explain how labelling and 
stigmatization affects the deviant nature of those who violate social norms.  
John Braithwaite’s (1989) theory outlined in Crime, Shame, and Reintegration referred to 
all societal processes of expressing disapproval and evoking remorse in the person being shamed. 
This theory drew from both Goffman’s (1963) theory of stigmatization and Lemert’s (1951) 
 14 
theory on primary and secondary deviance. Goffman’s (1963) concepts on shame and 
stigmatization were used to explain reintegrative and disintegrative shaming, while Lemert’s 
(1951) theory was used in defining a labelling theory. In general, Braithwaite’s (1989) theory 
utilized labelling theory – a theory that posits that some individuals continue to commit crime or 
engage in deviant acts due to the label that they have been given.  
Braithwaite (1989) noted that life circumstances impact interdependency. The most 
important of these circumstances include individuals who are between the ages of 15 and 25, 
married, female, and employed, and who have high employment and educational goals. He 
argued that interdependent persons are more susceptible to shaming, and societies that have 
increased interdependencies among its citizens are more likely to be communitarian. Braithwaite 
(1989) identified two types of shaming constructed by interdependency and communitarianism: 
shaming that is followed by reintegration; and shaming that becomes stigmatization.  
Reintegrative shaming is shaming that occurs as an exchange between the injured parties 
and the perpetrator. This type of shaming is followed by efforts to reintegrate the perpetrator 
back into the community as a law-abiding and respectable citizen. The efforts of reintegration are 
often words or gestures of forgiveness or ceremonies to remove the deviant label on the 
perpetrator. In essence, the act is labelled as evil, while the identity of the perpetrator is labelled 
as essentially good. Moreover, societies that utilized reintegrative shaming have lower crime 
rates, due to disapproval being dispensed without stigmatizing labels being instilled (Braithwaite, 
1989).  
In the second type of shaming, Braithwaite (1989) stated that shaming occurs as part of 
an individual’s stigmatization. He argued that stigmatization is disintegrative shaming, where no 
effort is made to reconcile the perpetrator with the community. Consequently, the perpetrator 
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becomes an outcast, with their deviance becoming their master status, or self-identity. In this 
regard, Braithwaite (1989) drew from the concepts posed by Howard Becker (1963), a labelling 
theorist who argued that deviant subculture formation partly arose from society’s negative 
reactions to an individual’s actions, and the subsequent labelling of the individual. He argued 
that a negative public label may encourage further deviance, which may lead to criminalization 
and a ‘deviant career’. This is the stage at which the label may become a master status for the 
outcasted individual, overriding all relationships outside of the deviant group (Becker, 1963).  
In the same sense, Braithwaite (1989) maintained the shaming that is stigmatizing 
increases the attractiveness of criminal subcultures, due to the sense that these subcultures reject 
the rejecters. Stigmatizing shaming also reduces an individual’s interdependencies, such as 
connections to family and pro-social peers, which increases the individual’s attraction to criminal 
subcultures.3 Subsequent participation in subculture groups increases interactions with criminal 
role models and enables training in techniques of crime, which makes the choice to engage in 
crime more attractive.4 Thus, just as reintegrative shaming lowers crime rates, when 
stigmatization is employed, crime rates increase.  
It should be recognized that while Braithwaite (1989) drew heavily from labelling 
theorists, such as Goffman, Lemert, and Becker, his concepts also integrated ideas from social 
control and social learning theories. Thus, his theory can be categorized as an integrated theory. 
Ultimately, although this description is only a short summary of Braithwaite’s (1989) theory, it 
helps to explain how shaming and stigmatization can lead to further delinquency.  
                                                 
3 This idea draws from social control theories, which stipulate that deviance and crime occur due to inadequate 
constraints; the constraints being positive connections to family, peers, or society. 
4 According to social learning theories, deviance and crime is learned through interactions with close peers. Within 
these relationships, individuals learn what is and what is not acceptable, based on the reactions of their peers to 
delinquency. 
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These theories were reviewed in an effort to connect the stigmatization of people who use 
drugs to their subsequent discrimination from informing research and policy. Goffman’s (1963) 
theory on stigmatization outlined how individuals become stigmatized based on undesired 
differences from what ‘normal’ society expects. Under his theory, people who use drugs are 
stigmatized based on their character traits – the perception of being weak willed, dishonest, 
dangerous, and having an unnatural passion. Similarly, Lemert (1951) argued that individuals are 
stigmatized according to the reactions of a group, community, or society to their ‘deviant’ 
characteristic. Differing from Goffman (1963), Lemert (1951) explained that when an excluded 
and stigmatized individual begins to identify with and display the behaviours of a similarly 
excluded group, secondary deviance occurs – resulting in ongoing deviance.  
However, both Goffman (1963) and Lemert (1951) acknowledged that those who share a 
stigma will associate with each other. It is evident in that those who use drugs are punished by 
criminal law and socially excluded from normative society; thus, it is not surprising that these 
individuals seek the support and companionship from similarly excluded individuals. This can 
lead to the further stigmatization of these individuals, negative self-perceptions, and continued 
drug use.  
Likewise, Braithwaite’s (1989) stigmatized shaming also explained how stigmatization 
leads to increased or continued drug use among those with substance addiction. Braithwaite 
(1989) differed from Goffman (1963) and Lemert (1951) in that he considered both positive 
shaming, which is reintegrative shaming, and negative shaming, such as disintegrative, or 
stigmatized, shaming. According to this theory, criminalizing and increasing punitive measures 
against people who use drugs, with no options for healthy reintegration into society, will only 
exacerbate their situations. That being said, laws and penalties meant to deter people who use 
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drugs from consuming illicit drugs will only be successful if there are positive supports or 
reintegrative options for the them to return to society in a positive way; if these supports are 
lacking, harsh laws and penalties will only further stigmatize and criminally entrench these 
individuals. Thus, according to this theory, traditional ‘tough-on-crime’ approaches will not be 
successful in reducing illicit drug use, due to the lack of options offered for healthy reintegration 
into society.  
Overall, these three theories can be combined to explain how those who use drugs are 
stigmatized and why they have been rejected from the drug policy debate. First, Goffman (1963) 
explained the societal reaction to those who use drugs problematically, and their subsequent 
social stigmatization. Second, Lemert’s (1951) concepts supported the criminalization process of 
these individuals, by illustrating how societal reactions to drug use have led to the stigmatization 
and the penalization under law of these individuals – leading to further drug use by the 
individual. The stigmatization of those who use drugs has subsequently resulted in this 
population being excluded from the policy debate. Lastly, Braithwaite’s (1989) theory lends the 
idea that positive shaming can be successfully applied to deviant actions; however, for shaming 
to occur without the outcome of stigmatization, positive supports or reintegrative options need to 
be offered. From this, it can be concluded that harsh laws, penalties, and stigmatization, will only 
exacerbate the current drug epidemic; yet positive reintegrative action may ultimately reduce the 
number of those with substance addiction.  
It is clear that the stigmatization of particular individuals often leads to further deviance. 
Moreover, as Goffman (1963) suggested, individuals with a stigma, including those who use 
drugs, are perceived by ‘normals’ as not quite human. This perception decreases the perceived 
value of this populations’ knowledge and lived experiences that could help inform drug policy. 
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Additionally, it could be argued that the continued discrimination of this population has 
negatively impacted their ability to contribute to policy development. Nonetheless, 
acknowledging the lived experiences and knowledge of those who have experienced drug use 
and addiction is the first step to reducing the current stigma against this population. 
The Dirty and the Dangerous: The Ugly Reality of Stigma 
Several researchers have indicated that the stigmatization of those who use drugs and 
people who inject drugs has contributed to the lack of research exploring this community’s views 
on drug policy (Lancaster et al., 2014; Lloyd, 2013; Tutenges et al., 2015).5 Tutenges et al. 
(2015) explained people who use drugs are often written and spoken about, yet this community is 
rarely given the chance to speak for themselves. They argued that this trend has resulted in a 
negative perception that vulnerable populations, such as those who use drugs, are too delusional 
to provide useful information about their experiences. Furthermore, people who use drugs are 
often stereotyped as homeless, unemployed, unclean, or dangerous (Australian Injecting and 
Illicit Drug Users League [AIVL], 2011; Lancaster et al., 2014). Thus, it is important to 
understand the current research literature on the stigmatization of people who use drugs. 
AIVL (2011) reasoned that the criminalization of drugs and drug use is a direct result of 
stigma. They argued that the criminalization of this population negatively affects their health and 
wellbeing. This is due to the barriers to health care and other resources that arise when 
stigmatization and discrimination occur. Additionally, the report maintained that very few people 
who use drugs are able to overcome being labelled a ‘drug user’, as terms such as ‘rehabilitated 
                                                 
5 Stigmatization is described as a negative stereotype which results in the discrimination and ostracism of a 
particular group or members of society (Australian Injecting and Illicit Drug Users League [AIVL], 2011). 
Stigmatization has always been a part of human society and while the stigmatized group may change over time, 
there is always a group or groups that are viewed negatively based their behaviour (AIVL, 2011). In recent years, 
the term ‘stigma’ has been increasingly associated with the discriminatory and prejudicial treatment of minority 
groups, such as individuals who are disabled or mentally ill (Lloyd, 2013). 
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drug user’, ‘treatment user’, ‘criminal user’, and ‘ex-user’ are still used to identify those who 
may have recovered from their addiction. Those who are able to transcend the status of a ‘user’ 
are often still associated with the drug using community as guest speakers, research subjects, or 
peer support (AIVL, 2001).  
Likewise, Lloyd (2013) found several themes regarding the stigmatization of people who 
use drugs. Lloyd (2013) concluded that the stigma associated with problematic drug use reflects 
wider public fears about illicit drug use in general. He argued that the rationale behind the fear of 
illicit drugs is complex but is often derived from the social history of the drugs, negative media 
attention, political rhetoric, and the fact that many illicit drugs are unfamiliar and poorly 
understood by the general population. Lloyd (2013) also noted specific stigmas that revolve 
around public conceptions of the ‘junkie’ or ‘addict’. A key aspect of this stigma is the injection 
of illicit drugs, as this was perceived by many as ‘dirty’. Additionally, Lloyd (2013) found that 
those addicted to drugs are perceived as dangerous and desperate – willing to commit crimes or 
odious acts to support their addiction.  
Moreover, the literature revealed that blame and personal responsibility often 
characterize the general population’s attitude towards this group of individuals. Lloyd (2013) 
reported that individuals with substance addiction are often blamed for their condition due to the 
misconception that they chose to use drugs. Thus, this group is viewed as having the personal 
responsibility to quit using illicit drugs.6 Similarly, Corrigan, Kuwabara, and O’Shaughnessy 
(2009) found that individuals addicted to drugs were viewed as significantly more responsible 
for their disorder than people with mental illness or physical disabilities. People who use drugs 
                                                 
6 Research on substance addiction has indicated that addiction is linked to genetic, psychological, and social factors, 
which helps to reduce the stigma of blame against people who use drugs and further challenges the idea that ceasing 
to use drugs is simply a matter of self-will (Lloyd, 2013). Despite this, the stigmatization of drug use continues 
within many societies. 
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were also viewed as substantially more dangerous and fear-evoking (Corrigan et al., 2009). The 
findings from these studies illustrated the stigmatization of people with substance addiction and 
demonstrated how discrimination results from such stereotypes and stigma.  
Peretti-Watel (2003) studied the public opinions and attitudes toward drug issues in 
France. They concluded that the stigmatization of those who use heroin is an obstacle to risk 
reduction policies. That being said, a minority of the participants endorsed a stereotyped 
perception of this population, viewing this group as ‘folk devils’ or people who are dangerous, 
have no will of their own, and corrupt young individuals (Peretti-Watel, 2003). Furthermore, a 
majority of the participants considered people who use heroin as dangerous towards their family 
and friends. These stigmatizing views were found to affect policy decisions on substance 
addiction and drug use. 
To further this understanding, Lancaster et al. (2015) presented people who inject drugs 
with the survey results of a previous study (see Lancaster et al., 2013) and asked them to 
interpret and discuss the results (Lancaster et al., 2015). Lancaster et al. (2015) found that the 
participants’ interpretations of the data were largely informed by the negative stereotypes of 
people who use drugs. For example, Lancaster et al. (2015) found that the participants 
unanimously agreed that needle and syringe programs were an important public health 
intervention, yet the results of the previous study indicated that some of those who use drugs did 
not support this intervention. The participants explained that their views could have reflected 
their internalized stigma about their own drug use – a perspective of shame (Lancaster et al., 
2015).  
The participants also explained why their peers were not universally supportive of drug 
law reform. They suggested that certain sub-groups of people who use drugs and specific drug 
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types are often perceived as being worse or more dangerous than others, leading to within-group 
stigma. The participants also explained that certain substances, like methamphetamine, are 
perceived as more dangerous, while those who used heroin generally faced more discrimination 
than other sub-group populations (Lancaster et al., 2015). Within-group stigma occurs when a 
marginalized group, such as those who inhale drugs, stigmatize or discriminate against another 
similarly marginalized group, such as those who inject drugs. This type of stigma can also be 
called horizontal stigma. Overall, this study found that people who use drugs’ own internalized 
stigma can negatively affect their interpretations of drug use and drug law reform, and can also 
lead to within-group, or horizontal, stigma.  
Similarly, Radcliffe and Stevens (2008) conducted qualitative interviews with people 
who use drugs and found that they both recognized their own lived experiences of drug use and 
viewed the existence of junkies as an ‘other’ or someone to be rejected. Many also indicated that 
their experiences of drug treatment were stigmatizing. They reported that their own self-
identities became tainted upon contact with the drug treatment facilities due to being viewed as a 
junkie or an addict. This view was particularly prominent among several groups of people who 
use drugs, including females, young people, and those who misuse prescription drugs and 
cannabis (Radcliffe & Stevens, 2008). In effect, several of the participants indicated that the fear 
of being seen using drug treatment services was a barrier to continuing treatment.  
Overall, it is evident that there are highly stigmatizing views towards people who use 
drugs and between sub-groups of those who use drugs. Moreover, it is clear that the 
internalization of these stigmatizing perceptions has affected this population. Nevertheless, the 
stigmatization of people who use drugs has continued to silence this population. This has 
resulted in limited research that addresses the perceptions of those who have experienced 
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substance addiction and has hindered the development of consumer-informed policy, prevention, 
and treatment interventions (Tutenges at al., 2015). In effect, various ill-informed and ill-
prepared drug strategies have been implemented by policy makers, who were eager to show 
initiative and social responsibility yet lacked a clear understanding of the people that the policies 
were meant to benefit (Tutenges et al., 2015). 
The review of the literature on the stigmatization of people who use drugs was critical in 
the development of the current project for several reasons. First, the findings demonstrated how 
drug use is characterized as deviant, consequently leading to further discrimination and 
stereotyping. This parallels the conclusions drawn from the theories presented. As a result, such 
barriers exclude people who use drugs from partaking in research and informing drug policy.  
Second, the connection between the theories and the research helped to explain why there 
is limited research focusing on the perceptions of those who use drugs. The stigmatization of this 
population has contributed to their exclusion from research. People who use drugs have been 
perceived as too delusional to provide useful information about their own lives and situations. 
Furthermore, they are often labelled as deviant and stigmatized as homeless, unemployed, 
unclean, or dangerous. These misconceptions have resulted in an overall lack of understanding of 
this population’s acute needs. Accordingly, there has been an over-reliance on biased and 
misinformed research to inform drug policies. This is an important discovery that is rationalized 
by both the theories and literature reviewed. Consequently, the research on the stigmatization of 
people who use drugs defends the need for more inclusive and comprehensive drug policy 
research.  
Third, this review allowed for a better understanding of the current findings. In other 
words, considering the stigmatization of this population led to a better appreciation of the 
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participant’s responses in the current project. That being said, the studies aided in the discussion 
of this project’s findings, particularly regarding the issue of stigmatization in Chapter 6. 
Ultimately, this review was necessary to understand the foundation of the current research. 
Fortunately, in recent years, academics have increasingly acknowledged the importance of 
people who use drugs’ perceptions. As a result, there has been a growing body of literature that 
analyzes the perceptions of those who use drugs, which will be explored below.   
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Chapter 3: Review of the Relevant Sources  
Literature Review 
Drug Laws: A User Perspective 
A number of studies on the perceptions of those who use drugs have focused on their 
views of either drug policy or drug strategies. For example, Greer and Ritter (2019) conducted a 
qualitative investigation with 37 participants on their opinions regarding drug laws and how they 
think drug laws could be improved. Results from this study indicated that decriminalization, 
legalization, and a medical or prescription model were all common preferences.  
The most supported model for drug reform was drug regulation through the medical 
system. Greer and Ritter (2019) noted that support for this model was largely based on its 
perceived helpfulness. The researchers also found that while many of the participants supported 
drug law reform, they shared the view that drug laws were unlikely to change. Moreover, the 
participants argued that a change in public opinion is necessary for any vital drug law reform to 
be successful (Greer & Ritter, 2019). Essentially, the participants supported drug law reform in 
Australia, yet were sceptical of these reforms occurring.  
Greer and Ritter (2020) furthered the discussion on the government’s role in regulating a 
legal market and why participants were sceptical of this approach. Some of the concerns related 
to the personal agency of people who use drugs under a medically regulated drug supply model. 
The researchers explained that the concerns stemmed from the participants’ lack of trust in the 
government, and their belief that the government is corrupt. Additionally, some of the 
participants argued that the government had vested interests in maintaining prohibition, as it 
creates jobs throughout the criminal justice system. Others believed that the government would 
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only support regulation of drug use to increase their own monetary profits from drug-related 
revenues (Greer & Ritter, 2020).  
The participants discussed both the potential harms and benefits of legalizing and 
medically regulating a drug supply. Potential harms included an increase in use and 
experimentation from those who otherwise would not have tried drugs. On the other hand, 
perceived benefits included an increase in the quality and the safety of drug supplies (Greer & 
Ritter, 2020). Ultimately, these findings suggested that while drug regulation through the 
medical system was supported by the participants, there were still concerns regarding this drug 
reform model.  
In Australia, Darke and Torok (2013) interviewed persons who inject drugs to learn their 
perspective on the legal status and perceived harms of five illicit drugs, including: heroin; 
methamphetamine; cocaine; 3,4-Methylenedioxymethamphetamine (MDMA); and cannabis. The 
researchers found that people who inject drugs viewed different drug types distinctively, with 
perceptions being related to their own drug use history. A majority of respondents supported 
legalizing cannabis, and there was modal support for the decriminalization of heroin. However, 
Darke and Torok (2013) found that this population did not favour legal changes for 
methamphetamine, cocaine, and MDMA. In terms of associated harm, methamphetamine was 
rated by participants as the most harmful, followed by cocaine, MDMA, heroin, and cannabis 
(Darke and Torok, 2013). Ultimately, lower levels of perceived harm led to increased support for 
the legalization of all substances and the decriminalization of heroin.  
In another Australian study, Lancaster et al. (2014) assessed the opinions people who use 
drugs on Australian drug policy and its subsequent strategies. They used survey information 
from the 2012 Ecstasy and Related Drugs Reporting System (EDRS) and the 2011 Illicit Drug 
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Reporting System (IDRS).7 Lancaster et al. (2014) found that support for legalizing cannabis was 
expressed strongly by both the IDRS and EDRS participants. However, while 44.3% of the 
EDRS participants supported the legalization of MDMA, only 24.9% of the IDRS participants 
did. As well, 54.9% of the IDRS participants supported the legalization of heroin, whereas only 
12.8% of the EDRS participants shared this support (Lancaster et al., 2014). Furthermore, 75.5% 
of the EDRS participants opposed the legalization of heroin, yet only 33.1% of the IDRS 
participants responded similarly. Ultimately, with the exception of support for the legalization of 
MDMA, a greater proportion of IDRS participants supported legalization for the personal use of 
each drug (Lancaster et al., 2014).  
Lancaster et al. (2014) also measured and compared the support for strategies to reduce 
the harms associated with heroin use. They noted significant differences in reported levels of 
support for all harm reduction and treatment interventions between the IDRS and EDRS 
participants. While 96.6% of IDRS and 83.6% of EDRS participants supported needle and 
syringe programs, and 80.5% of IDRS and 63.3% of EDRS participants supported regulated 
injecting rooms, opinions differed in regard to treatment inventions (Lancaster et al., 2014). 
Moreover, Lancaster et al. (2014) reported that IDRS participants were more supportive of 
methadone and buprenorphine maintenance treatment and rapid detoxification therapy than the 
EDRS participants.  
The most notable differences were observed in responses to the trial of prescribed heroin, 
as 74.6% of IDRS participants supported the implementation of prescribed heroin, while only 
30.6% of EDRS participants shared this support (Lancaster et al., 2014). Furthermore, 33.4% of 
                                                 
7 The EDRS is used to monitor the ever-evolving patterns of drug use among those who regularly use MDMA and 
psychostimulants, such as cocaine and methamphetamine, as well as examines drug prices, purity, and perceived 
availability (Lancaster et al., 2014). Comparatively, the IDRS monitors patterns of use and drug market trends 
among people who inject drugs. 
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EDRS participants opposed this trial in Australia, compared to 13.1% of IDRS participants 
(Lancaster et al., 2014). Ultimately, the findings of this study show that the views on drug policy 
interventions in Australia vary significantly between people who inject drugs and those who 
regularly use MDMA.  
To further their understanding, Lancaster et al. (2015) conducted three qualitative focus 
groups in Australia with participants who had a history of injection drug use. The participants 
were presented with the survey results from the 2011 IDRS (see Lancaster et al., 2013) and were 
asked to discuss whether they supported or opposed each policy item. The discussions served to 
elicit participants’ interpretations of the survey findings. The researchers found that the 
participants’ opinions and interpretations of the quantitative data was largely based on an 
amalgamation of the participants’ opinions, knowledge, and lived experiences. They noted that 
their peers might not have been universally supportive of drug law reform due to differences in 
their preferred drug type, and their perception of the harms caused by each drug. Moreover, the 
participants wished for more non-punitive and non-discriminatory treatment opportunities. 
Evidently, there are differences in opinions on drug policy within different populations of people 
who use drugs (Lancaster et al., 2015). Therefore, these findings speak to the diversity of 
attitudes and experiences within the drug using population. 
The Good, the Bad, and the Ugly: Thoughts on Drug Strategies  
Many research studies have also explored the perceptions those who use drugs on general 
and specific drug strategies, which include methadone maintenance programs and harm 
reduction initiatives. Lancaster et al. (2013) found that respondents who used drugs strongly 
supported needle and syringe programs (96.8%), methadone and buprenorphine maintenance 
programs (86.3%), drug treatment either than methadone (82.7%), regulated injecting rooms 
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(80.5%), and a trial of prescribed heroin (74.6%). Additionally, in their comparison of drug using 
groups, Lancaster et al. (2014) found that both the IDRS and EDRS groups supported harm 
reduction measures, such as needle and syringe programs and regulated injection rooms. 
Evidently, harm reduction strategies are supported among many of those who use substances.  
Several studies examined the general perceptions of those who use illicit drugs on various 
service providers. For example, Neale (1998) conducted interviews with people who use drugs in 
England to understand views on drug service providers, such as: specialist drug agencies; 
counsellors; general practitioners; pharmacists and pharmacy staff; needle exchanges; 
detoxification and rehabilitation units; self-help groups; and criminal justice agencies. 
Participants commented positively on the specialist knowledge of staff, the availability of advice 
and help, the provision of a wide range of facilities, and staff being accessible, willing to listen 
and having a good attitude (Neale, 1998). The participants noted that negative attributes of 
service providers included: frequent staff changes; lack of knowledge; workers trying to take 
control, or being dishonest, about the range of treatment options; inconsistent prescribing 
policies; strict appointment times; stereotyping; and not trusting the clients.  
Additionally, Neale (1998) found gender differences in drug service utilization. Men 
were more likely than women to use specialist services, such as needle exchanges, detoxification 
units, and self-help groups. Comparatively, women were more likely than men to use generic 
services, such as those provided by doctors and pharmacists, drug counsellors, and written 
material. Lastly, Neale (1998) found that women were more likely than men to report 
dissatisfaction with the services provided for those who use drugs.  
Over a decade later, Neale et al. (2015) conducted five focus group interviews in 
England. A majority of the participants felt that many of the service providers expected too much 
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from the service users. Furthermore, in all the focus groups, participants reported frustration with 
service providers who failed to consider the complex needs and vulnerable circumstances of each 
individual. For example, Neale et al. (2015) noted that many argued that the seemingly positive 
goals for their recovery could have negative consequences on their lives, such as over-
confidence, stress from the pressure to gain employment, constant self-reflection that prevents 
closure, and avoiding people to prevent relapse. These consequences serve to show the complex 
needs and vulnerable circumstances of each individual struggling with addiction. Overall, Neale 
et al. (2015) concluded that given the participants’ experience with such programs, they could 
provide valuable insight into the perceptions of service providers.  
In a similar study, Kolind (2007) used semi-structured interviews with the consumers of 
the Danish Methadone Project, in order to gain their perspective on the advantages and 
limitations of this program. The Methadone Project varied from the standard methadone 
treatment program in several ways. The program featured a reduced client-counsellor ratio, and 
frequent and accessible individual counselling. Moreover, the program’s drop-in centers were 
open more than three hours a day and included health-related services. Lastly, the program 
experimented with methadone dispensing, such as intravenous methadone and individual face-to-
face flexible dispensing. Those who utilized this program found that the attitudes of their 
counsellors were positive and attentive, and they commented positively on the accessibility of 
spontaneous counselling and the spaces that facilitated non-stigmatizing social encounters 
(Kolind, 2007).  
While the Danish Methadone Project received positive feedback, Fischer, Chin, Kuo, 
Kirst, and Vlahov (2002) found less supportive views in their Canadian-based study. Fischer et 
al. (2002) conducted focus groups with individuals who use opioids in Canada’s three largest 
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cities – Toronto, Montreal, and Vancouver. This study examined participant views on methadone 
and other opiate prescription treatment. The study found that many perceived it to be punitive 
and controlling, pervasively regimented, and disempowering. Moreover, the majority of 
participants felt that methadone was harmful to the body, citing negative side effects, such as 
back-aches, constipation, sweating, body aches, weight gain, headaches, nausea, sleepiness, loss 
of sex drive, numbness, and seizures (Fischer et al., 2002).  
Furthermore, many of the participants who had been on a methadone treatment program 
believed that methadone was more addictive than heroin. The participants noted that the structure 
of the methadone program limited their ability to work, travel, and socialize. Moreover, many 
perceived the treatment providers and staff to be ‘out of touch’ with the clients’ experiences, 
disinterested, and profit driven. Comparatively, those who positively viewed the methadone 
treatment programs noted its benefits in helping them reach sobriety, reducing their need to 
commit crimes to support their addiction, providing structure and stability in their lives, and 
being cheaper, more accessible, and more reliable than heroin (Fischer et al., 2002).  
Fischer et al. (2002) also noted that the participants had divergent beliefs of what 
constituted an ideal treatment program. While some believed that the ideal treatment would be a 
program that prioritizes detox and abstinence-based treatment programs, others believed that an 
ideal program would focus more on harm reduction. Regardless, all participants strongly 
expressed the need for choice and freedom in both the design and course of their treatment 
(Fischer et al., 2002).  
Interestingly, Fischer et al. (2002) found that although participants supported the idea of 
having a prescription heroin program available, opinions regarding the eligibility criteria, 
structure, and objectives varied (Fischer et al., 2002). Many of the participants agreed that heroin 
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prescription programs should be highly regulated and supervised. Some positive benefits of 
implementing a heroin prescription program included: a reduction in drug-related crime; a 
reduction in the use of other substances; and increased stabilization (Fischer et al., 2002).  
Similarly, in Montagne’s (2002) study on the perceptions of Canadians who use opioids 
on methadone maintenance programs, a majority of the respondents indicated that they would 
prefer heroin maintenance, while 18.0% preferred buprenorphine, and the other treatments were 
chosen by 5.0% or less of the respondents. These studies demonstrated the difference in 
perceptions and experiences between those who participate in methadone treatment and those 
who offer this treatment, develop policy, or research addiction and pharmacotherapies (Fischer et 
al., 2002; Montagne, 2002).  
Lutnick, Case, and Kral (2012) presented another study that considered the views of the 
consumer group on a specific drug strategy. Lutnick et al. (2012) completed semi-structured 
interviews on people who inject drugs in San Francisco, California, to assess their perceptions on 
increasing services for them within pharmacies. While many of the participants welcomed more 
services for people who inject drugs, they voiced concerns with the implementation of such 
services in pharmacies. Many reported negative experiences resulting in the perception of 
pharmacists and pharmacy staff as judgemental and unhelpful. Additionally, none of the 11 
participants had been offered information by pharmacy staff about testing services, HIV risk 
reduction, or drug treatment services (Lutnick et al., 2012). Further, in discussing syringe 
exchange programs in pharmacies, many voiced concerns with privacy and accessibility and 
noted that they feel more comfortable receiving services from community clinics. Overall, while 
the participants noted some benefits to expanding services in pharmacies, issues of privacy and 
negative experiences with pharmacists and pharmacy staff were most concerning.  
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The previous studies have helped shed light on the various views on effective and 
efficient addiction related services and service providers. All participants strongly expressed the 
need for choice and freedom in the design and the course of their treatment (Fischer et al., 2002). 
Moreover, many of the participants expressed frustration with service providers (Neale et al., 
2015). These findings demonstrate the importance of incorporating the views of people who use 
drugs when creating and implementing drug strategies.  
It all Comes Down to This: A Summary of the Literature 
Many studies on the perceptions of those who use drugs have focused on their views of 
either drug policy and legislation or drug strategies, such as methadone programs or harm 
reduction initiatives. The findings highlight the diversity of attitudes and experiences among 
people who use drugs. For example, it was reported that those who use drugs have different 
opinions on what constitutes an effective and efficient addiction related service and service 
provider. Despite the differences, many participants strongly expressed the desire for choice and 
freedom in the design and course of their treatment. 
After reviewing the literature in this area, it is clear that there is tension between the 
opinions and lived experiences of this population and the reality of the policies and practices 
implemented. Although it is clear that those who use drugs have varying views, their opinions 
are critical in contributing to the implementation of effective and efficient drug policies and 
strategies. These opinions should be considered an important step in creating an ethically sound 
approach to drug treatment (Kolind, 2007).  
Canadian Drug Policy: The Evolution 
The criminalization of certain drugs under Canadian law is fairly recent. Laws 
prohibiting the use of cannabis, heroin, cocaine, and other substances were first passed in the 
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early 1900s and were criticized for relying heavily on the social, cultural, and moral contexts of 
the time (Malleck, 2015; Toronto Public Health [TPH], 2018). As such, academics have argued 
that certain substances were first prohibited due to their status as a public health risk (MacKay, 
2018). In other words, they have maintained that the government prohibited these substances 
based on their potential harms to society, while only marginally considering their potential health 
risks. Thus, the motivation to implement these early laws were largely motivated by social ideals 
and control (MacKay, 2018). This ideology led to over a century of prohibitionist drug policies 
in Canada that have relied on criminal law to control drug supplies and to punish those in 
possession of illicit substances (Erickson, 1992). 
Since 2015, Canadian Prime Minister (PM) Justin Trudeau and the Liberal Party have 
worked to reform Canadian drug policy and legislation. They implemented several policies on 
drug possession and use, including the legalization of cannabis in 2018 (Department of Justice, 
2018). Moreover, this government increased its efforts towards researching and implementing 
‘evidence-based’ drug strategies. The implementation of these strategies, such as take-home 
naloxone kits, OPSs, and opioid agonist therapy, has been successful in preventing many drug-
related deaths in Canada in recent years (Irvine et al., 2019).  
While these initiatives are effective in reducing various drug-related harms, including 
fatal overdoses, the rates of drug-related overdose deaths have continued to increase each year. 
This increase is related to the rise in fentanyl and other high powered opioid contaminated drugs 
(Government of Canada, 2018c; Fischer, Vojtila, & Rehm, 2018; Irvine et al., 2019; Kennedy et 
al., 2019). In an effort to better understand the implications of these recent changes, and to 
appreciate the results and recommendations of this research, it is necessary to analyze the history 
of Canadian drug policy.  
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Moral Panics and Racism: The Beginning of Drug Prohibition 
The first legal framework of drug control in Canada was introduced in 1908, with the 
implementation of the Opium Act (MacKay, 2018; Riley, 1998). While regulations on all 
medicines, tobacco, and alcohol were introduced at this time, the Opium Act was the first 
Canadian document that prohibited a drug (Riley, 1998). The Opium Act specifically prohibited 
the importation, manufacture, and sale of Opium for non-medical purposes, as well as imposed 
criminal penalties for using and trafficking this substance (MacKay, 2018; Malleck, 2015).  
Scholars have argued that the Opium Act emerged directly from racial violence (Malleck, 
1997). In 1907, there were rumours that Japanese labourers were set to arrive in Vancouver, 
causing white residents to riot through Vancouver’s Chinatown. Deputy Minister of Labour 
William Lyon Mackenzie King was dispatched by the Federal Government to Vancouver. King 
considered the damages to Japanese and Chinese businesses, and recommended reparation 
payments (Malleck, 1997). King received applications for damages to two opium manufacturers. 
These applications led a review of opium smoking in the city, which resulted in the 
recommendation to prohibit the substance (Malleck, 1997).8 The Opium Act was subsequently 
passed through the House of Commons with little discussion.  
In 1911, the Opium Act was replaced by the Opium and Narcotic Drug Act (ONDA), 
which prohibited the use of other opioids, such as morphine, and cocaine (Riley, 1998). The 
ONDA also added harsher penalties, such as imprisonment, for individuals caught using the 
prohibited substances (TPH, 2018). In 1922, the ONDA was amended to include the penalty of 
deportation for immigrant offenders. Amendments also stipulated that those charged under this 
act were considered guilty until proven innocent (Hewitt, 2004). Further, in 1923 cannabis was 
                                                 
8 Scholars have argued that King’s motives were based on regulating the behaviour of the Chinese labourers, a group 
that was gaining upward mobility in BC through the sale opium (Malleck, 1997).  
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added to the list of prohibited substances (Riley, 1998). The ONDA remained in effect until 1961 
(TPH, 2018).  
Early Canadian drug policy was most notably influenced by the strong moralistic values 
and the Eurocentric and racist attitudes of society (Gordon, 2006; MacKay, 2018). Before 1908, 
many Canadians opposed the consumption of drugs and alcohol, as they believed these would 
negatively affect the morality of the consumer (MacKay, 2018). Organizations, such as the 
Women’s Christian Temperance Union, ardently encouraged abstaining from drugs and alcohol 
as a means to improve personal health and religious morality. These moralistic values permeated 
Euro-Canadian society in the early twentieth century, which largely influenced the creation of 
law and policy (MacKay, 2018). 
Moreover, in the late 1800s and early 1900s, Canadian society was openly hostile 
towards immigrants who were deemed inassimilable, in particular those of Chinese heritage 
(Hewitt, 2001; Malleck, 1997). These racist ideologies were prominent in popular literature, 
which affected policy development. Emily Murphy’s The Black Candle outlined the evils of the 
drug trade. 9 The sentiments shared by Murphy (1922) were focused on the dangers of opium, 
cocaine, and cannabis. Murphy (1922) blamed the Canadian immigrant population for the supply 
and sale of these substances – specifically focusing on the Chinese immigrant population when 
discussing opium. Murphy’s (1922) work is argued to have contributed to the amendments made 
to the ONDA in 1922 and 1923 (Jackel, Cavanaugh, & Marshall, 2019).  
The popular rhetoric on opium and its criminalization was underpinned by anti-Chinese 
sentiments, and Chinese-Canadians were heavily affected by the imposed legislation (Gordon, 
2006; Hewitt, 2004). For example, between 1923 and 1932, nearly two percent of the Chinese 
                                                 
9 Murphy was a Canadian author, women’s right activist, and judge. 
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population in Canada were deported under the ONDA, and in 1922 alone, nearly three percent of 
this population were convicted (Hewitt, 2004). Similar to the criminalization of opium, the use of 
both cannabis and cocaine were widely viewed as drugs used by the non-Euro-Canadian ‘other’ 
and were prohibited. This ideology mirrored the United States (US), who strictly prohibited the 
use of cannabis and crack-cocaine since those of Hispanic and African descent were viewed as 
using these substances. Overall, early Canadian drug policy was largely affected by the views 
and attitudes of society, which resulted in the prohibition and criminalization of various 
substances (Gordon, 2006).  
While the ONDA prohibited and criminalized several substances, there were no 
provisions in the act for the treatment of addictions (Hewitt, 2004). Specifically, in 1923, the 
Federal Minister of Health acknowledged that the government had failed to support addiction 
treatment, as it was considered a provincial responsibility (Hewitt, 2004). Further, in 1933, a 
Member of Parliament questioned the availability of funding for the treatment of substance 
addictions. It was reported that there was no funding available and that addiction treatment was a 
Provincial responsibility (Hewitt, 2004). As such, the Federal Government’s first response to 
substance use was to treat it as a criminal problem; thus, federal money was distributed among 
law enforcement agencies and correctional facilities, rather than for treatment (Hewitt, 2004). 
It is important to understand the history of Canadian drug policy, as these laws and 
strategies deeply affect current Canadian policy on illicit substances. The earliest of drug policies 
in Canada were based on moralistic attitudes and racist ideals, with little regard for empirical 
research or scientific thought – let alone the opinions and insights of the people that they sought 
to criminalize. Subsequently, the prohibitionist foundation of these policies has been the basis of 
the laws and strategies on drugs developed in Canada. Thus, it is not surprising that these 
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policies have continued to be ineffective and inefficient in addressing substance use and 
addiction. Unfortunately, a reliance on this prohibitionist foundation has continued throughout 
the past century.  
Changes in the 1960s and 1970s: Groovy or Far Out? 
While Canadian drug policy and legislation changed in 1961, these modifications 
reinforced the division between licit and illicit drugs. The United Nations (UN) codified 
international drug prohibition and regulation through the Single Convention on Narcotic Drugs 
and the Convention on Psychotropic Substances, both of which Canada is a signatory (UN, 1961 
& 1971). The Canadian Government passed the Narcotic Control Act (NCA) in 1961 to 
implement the provisions that were outlined in the Single Convention on Narcotic Drugs. The 
substances referred to as ‘narcotics’ under the NCA included heroin, cocaine, and cannabis 
(Canadian Foundation for Drug Policy [CFDP], 2001). Under the NCA, the possession of a 
narcotic substance was prohibited, with a penalty of up to seven years imprisonment. Moreover, 
possession for the purpose of trafficking, and trafficking, cultivating, importing, and exporting 
were all heavily penalized (CFDP, 2001). 
Despite the provisions against illicit drug use under the NCA, the use of substances, such 
as cannabis, lysergic acid diethylamide (LSD), and cocaine, were popular among youth in the 
1960s and 1970s (Marquis, 2005). This led to a moral panic among older generations (Marquis, 
2005). Further, the increased use of substances among youth pressured the Federal Government 
to consider liberalizing its drug laws, as the court system was becoming inundated with a rising 
number of youth sentenced with drug offences (Riley, 1998). Canadian drug policy followed the 
pattern in the US – as the impetus to change drug laws occurred suddenly when middle- and 
upper-class Caucasian youth became heavily involved in the system.  
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In 1969, in response to growing social and political concerns, the Federal Government, 
under PM Pierre Trudeau, formed the Commission of Inquiry into the Non-Medical Use of 
Drugs, which is popularly referred to as the Le Dain Commission (Marquis, 2005). This 
commission concluded that drug prohibition resulted in high social, political, and economical 
costs (Le Dain, 1973). As such, a less punitive approach was recommended to discourage the use 
of illicit substances and reduce harm. This included a gradual withdrawal from criminal 
sanctions against drug use, particularly for the use of cannabis (Le Dain, 1973). 
The conclusions of this Commission were ignored by the Federal Government; however, 
an amendment was made to the NCA in 1969 allowing prosecutors to proceed summarily in 
possession cases, resulting in fewer penalties for drug use. Further, the Canadian Criminal Code 
was amended in the early 1970s to allow for absolute and conditional discharge options in drug 
possession cases (Riley, 1998). While small changes were made to the existing legislation, 
Canadian drug policy was still very much centred around the idea that drugs should be 
prohibited, and those use who drugs should be criminalized.  
The developments to Canadian drug policy in the 1960s and 1970s did not incorporate 
empirical evidence or scientific thought. Rather, these policies were largely influenced by the 
reactions of middle- and upper-class Euro-Canadian adults – as mirrored in the US. This 
population opposed the rampant use of illicit substances among younger generations and feared 
their subsequent involvement with the criminal justice system. As a result, the Le Dain 
Commission was formed, and amendments were made to the NCA. Despite these actions, 
Canadian drug policy remained soundly prohibitionist in nature, and the recommendations made 
by the Le Dain Commission were ignored. Essentially, the Federal Government disregarded the 
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research conducted by the commission to appeal to the masses of those who moralistically 
opposed drug use.  
One Step Forward, Two Steps Back: Drug Policy in the 1980s and 1990s 
By the mid 1980s, it was clear that there were serious limitations regarding the role of 
law enforcement and education. However, in 1986, PM Brian Mulroney announced that Canada 
was in the midst of a drug epidemic, despite reports indicating that drug use was declining 
(Erickson, 1992; Jensen & Gerber, 1993). This announcement came just two days after US 
President Ronald Reagan declared a national ‘War on Drugs’. In response, the Canadian 
Government created a federal secretariat whose task was to consult with community groups and 
agencies to create a new national focus on a drug strategy (Erickson, 1992).  
In May 1987, the Federal Government released the Canada Drug Strategy, which 
included a ‘four-pillar’ approach to combating illicit drug use. The four pillars included 
prevention, harm reduction, treatment, and enforcement, although the majority of federal funding 
was enforcement driven (TPH, 2018). Despite this shortcoming, the inclusion of the four-pillar 
approach marked a significant step towards a national strategy that incorporated treatment and 
harm reduction. This strategy was funded for an initial five-year term ending in April 1992 and 
was subsequently renewed for another five years (Riley, 1998). Following this term, heavy 
financial cuts were made to Canada’s drug-related initiatives and the Policy and Research Unit of 
the Canadian Centre on Substance Abuse, which had been researching and documenting 
alternatives to drug prohibition, was closed (Riley, 1998).  
Further, Canada introduced the Controlled Drugs and Substances Act in 1996, which 
replaced the NCA. This act did not consider the expert opinion from the Le Dain Commission 
(TPH, 2018). Rather, the new legislation remained soundly prohibitionist in nature, and further 
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powers were given to police and prosecutors to increase efficiency in processing those who use 
drugs and sellers (Riley, 1998; Hathaway & Tousaw, 2008). Despite the attempt to provide a 
balanced approach to combating illicit drug use during the implementation of the Canada Drug 
Strategy, the dominant policy regarding illicit drugs remained one of criminal prohibition. 
The politics surrounding PM Mulroney’s term in Federal Office were associated with the 
Canadian drug ‘epidemic’ in 1986. In previous decades, the factors that affected drug policy 
were largely based on societal attitudes and moral panics, yet the initiation of the Canada Drug 
Strategy and the renewed War on Drugs also appear to have been influenced by politics (Jensen 
& Gerber, 1993). Mulroney and the Progressive Conservative Party obtained a majority vote in 
1984, however, within a year, his approval ratings dropped. By 1986, PM Mulroney’s approval 
ratings stood at 37 percent (Jensen & Gerber, 1993). In order to bolster support for his Party, PM 
Mulroney announced the Canadian drug epidemic, which would ultimately create an opportunity 
for drug policy change; however, little change was made and progression under the Canada 
Drug Strategy was short lived.  
Similar to previous decades, the Federal Government continued to respond slowly to the 
treatment of drug addiction. In 1987, amidst growing concerns over the spread of human 
immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS), the Canadian 
government funded needle syringe programming (NSP). The Federal Health Minister allocated 
$100,000 to each province that agreed to match equal funding for the NSP. However, after only 
two years, Federal funding for the NSPs ceased, and provinces and municipalities were left to 
fund this harm reduction strategy on their own (Hayle, 2018). The Canadian Government’s 
unwillingness to provide further funding was associated with the distribution of power over 
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healthcare (Hayle, 2018). While the Federal Government controlled drug policy, little support 
was given to treatment and harm reduction.  
Moving into the Early 21st Century: Progressive Changes to Regressive Policy   
The Canadian Federal Government was led by the Liberal Party at the turn of the 21st 
century. This Party emphasized the need for harm reduction initiatives and was actively seeking 
change to drug policy. In 2003, North America’s first sanctioned SIF, Insite, opened in the 
Downtown Eastside (DTES) of Vancouver, BC (Dooling & Rachlis, 2010). This SIF allowed 
individuals who use drugs to safely inject in a clean environment, with nurses and other medical 
personnel available on site to provide sterile injection equipment, to aid in cases of overdose, and 
to provide educational material and treatment referrals (Dooling & Rachlis, 2010). The overall 
goals of SIFs were to increase access to health care and addiction services, reduce the spread of 
infectious diseases, reduce overdose related deaths, and reduce public injection use (Hathaway & 
Tousaw, 2008).  
To operate legally, the Canadian Liberal Government exempted Insite from certain 
provisions of the Controlled Drugs and Substances Act relating to trafficking (Dooling & 
Rachlis, 2010). Insite was rigorously evaluated in the years following its implementation and 
multiple studies found positive results, which included the prevention of overdose deaths, a 
decrease in needle-sharing, a reduction in public injecting and injection-related litter, a reduction 
in vehicle break-ins and theft, and an increase in referrals to methadone treatment (Dooling & 
Rachlis, 2010, 1441). Despite these results, the future of Insite, and further harm reduction 
measures, became uncertain when the Conservative Party, led by Stephen Harper, was elected 
into office in 2006.  
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Despite the benefits of Insite, PM Harper did not support the harm reduction initiatives, 
and pulled the federal funding (Dooling & Rachlis, 2010). In 2007, the Federal Government 
released the National Anti-Drug Strategy, which removed harm reduction from Canada’s four-
pillar drug strategy while shifting the focus to the role of law enforcement (TPH, 2018). In 2008, 
the leadership for the new anti-drug mandate was removed from Health Canada and relocated 
within the Department of Justice, which demonstrated a clear shift in ideology within the 
government (van der Meulen, De Shalit, & Ka Hon Chu, 2018). This government also pushed to 
intensify the War on Drugs by proposing a ‘tough-on-crime’ approach (Hyshka, Butter-McPhee, 
Elliot, Wood, & Kerr, 2012; van der Meulen et al., 2018).  
Canadian drug policy under PM Harper was not supported by evidence-based research or 
public demand (Hyshka et al., 2012). Further, the retraction of the harm reduction pillar in the 
National Anti-Drug Strategy and the tough-on-crime legislation contradicted the 
recommendations of the Global Commission on Drug Policy, the Supreme Court of Canada, and 
international trends (Hyshka et al., 2012). Thus, drug policy during this time was motivated by 
ideological principles of punishment and retribution, rather than by evidence-based research. It is 
not surprising that international observers viewed Canadian drug policies as anachronistic and 
ill-advised (Hyshka et al., 2012).  
Finally Advancing: Drug Policy Changes in 2015 
In 2015, the Liberal Party, with leader Justin Trudeau, won the election and initiated 
changes to Canadian drug policy. During its campaign, the Liberal Party was intentional in its 
agenda to legalize cannabis and increase harm reduction initiatives (Liberal Party of Canada, 
2013). In 2016, Canada’s current drug strategy, the Canadian Drugs and Substances Strategy, 
was released. This strategy is a comprehensive, collaborative, compassionate, and evidence-
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based approach to drug policy that includes the four-pillar approach (Government of Canada, 
2019a). Further, PM Trudeau outlined his intentions to legalize and regulate cannabis possession 
and use and to obtain bilateral agreements with each province and territory to improve access to 
mental health and addiction services (Trudeau, 2015 & 2017).  
The Federal Government authorized legislative changes to fulfill their promises. On 
October 17th, 2018, the Cannabis Act was enacted in Canada, making cannabis possession and 
use legal for the first time since 1923. This act implemented a strict legal framework for 
controlling the production, distribution, sale, and possession of cannabis across Canada 
(Department of Justice, 2018). The goals of the act were designed to keep cannabis away from 
youth; to ensure that profits from cannabis sales would not support organized crime; and to 
protect public health and safety by making it legal for anyone over the age of 18 to access legal 
cannabis (Department of Justice, 2018).  
In 2017, the Good Samaritan Drug Overdose Act was enacted (Government of Canada, 
2018a). This act provides some legal protection for individuals who seek emergency help during 
an overdose, including protection from being charged with possession of a controlled substance 
or with a breach of conditions regarding drug possession (Government of Canada, 2018a). This 
act applies to anyone who seeks emergency support during an overdose, including the person 
experiencing the overdose and anyone else who may have been at the scene (Government of 
Canada, 2018a).   
Trudeau’s Government also supported the implementation of several harm reduction 
initiatives across the country. This government recognized that while treatment for addictions 
should be available, not everyone is an ideal candidate. In the meantime, the Trudeau 
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government supported several harm reduction initiatives, including: naloxone programs10; 
needle-exchange programs; and SIFs, SCFs11, and OPSs12 (Government of Canada, 2018b). 
Naloxone has been widely dispensed in many provinces and has been successful in reducing 
opioid-related deaths (Karamouzian, Kuo, Crabtree, & Buxton, in press). Moreover, a large body 
of evidence has demonstrated the effects of SIFs, SCFs, and OPSs on reducing various drug-
related risks and harms, including fatal overdoses (Kennedy et al., 2019). Evidently, the current 
Federal Government has taken steps to support harm reduction measures and to reduce the 
effects of substance addiction on vulnerable populations.  
To Dismantle a Century of Poor Decisions 
Following the analysis of Canada’s drug policy history, it is evident that this policy was 
largely based on social and political factors, rather than on scientific research and evidence-based 
practices. This led to prohibitionist policy that had an array of adverse outcomes, including high 
drug overdose rates, high rates of infectious diseases, high rates of incarceration for drug 
offences, high law enforcement costs, and no significant reductions in drug use (Hathaway & 
Tousaw, 2008). Evidently, prohibiting the use of certain drugs will not end drug use and 
addiction, nor decrease the associated harms.  
It is encouraging that the recent changes to drug policy under the Liberal Government 
have focused on reducing the harms associated with illicit drug use, rather than strictly 
prohibiting substances and criminalizing those that use drugs. The current harm reduction-based 
drug strategies attempt to aid the most vulnerable and drug-entrenched populations in Canada, 
                                                 
10 Naloxone reverses the effects of opioid-related overdoses. 
11 SCFs are similar in nature to SIFs, except the customer may only inject their drugs in SIFs, whereas SCFs allow 
all forms of consumption (Ponciano, 2018). 
12 OPSs are similar to SCFs, but are temporary facilities meant to address an immediate need in the community and 
can be in operation within weeks (Ponciano, 2018). 
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which is a historically overlooked population. Ultimately, these strategies are encouraging in that 
they are a significant step towards using empirical evidence and scientific thought in Canadian 
drug policy development.  
Nonetheless, some still contend that the current harm reduction strategies are inadequate 
to address drug use and its associated harms. Van der Meulen et al. (2018) called for a rights-
based, participant-driven, and gendered focus on drug policy development that recognizes 
substance use as a health issue, eliminates the use of incarceration and punishment for minor 
drug offences, and ensures that all drug treatment services are evidence-informed. Lavalley, 
Kastor, Valleriani, and McNeil (2018) argued that while drugs remain criminalized, advances 
toward addressing the overdose epidemic among vulnerable populations will remain futile. They 
also maintained that despite the recent increase in harm reduction practices, drug criminalization 
and policing practices limit the effectiveness of these measures (Lavalley et al., 2018).  
Both van der Meulen et al. (2018) and Lavalley et al. (2018) contended that further 
improvements to Canadian drug policy should include drug decriminalization and evidence-
informed services for addiction. Ultimately, these academics argued that while drugs remain 
illegal, those who use drugs will continue to be marginalized from society and further 
criminalized, decreasing the overall effectiveness of these specific strategies. Therefore, although 
the Federal Government has made progressive changes to Canadian drug policy, it is clear that 
further research on evidence-based policies and practices are warranted.  
So What? 
In reviewing the literature and considering the changes to Canadian drug policy in recent 
years, it is clear that a present-day study exploring the perceptions of those who have 
experienced substance addiction is needed. Accordingly, Canadian drug policy was reviewed 
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extensively for several reasons. First, to understand why the prohibition of drugs has been 
unsuccessful in addressing drug use and substance addiction, one needs to understand the 
establishment of this policy. As outlined, the foundation of Canadian drug policy is based on 
social and political factors, rather than on scientific research and evidence-based practices. This 
has resulted in prohibitionist policies that do not adequately address drug use and addiction. 
Moreover, while harm reduction strategies are a positive step towards using evidence-based 
practices and ensuring public safety, social and political factors remain an obstacle for serious 
drug law reform. Essentially, the social and political foundation of Canadian drug policy hinders 
major drug law reform, resulting in the continued implementation of ineffective policies.  
Second, to recommend appropriate and effective action, one needs to understand the 
evolution of Canadian drug policy. Currently, Canada is in the midst of a drug-related overdose 
epidemic and has hastily pushed forward new drug policy, legislation, and strategies. While the 
harm reduction strategies have been successful in reducing the harms associated with substance 
use, there is clearly a need for changes to drug policy. As such, future recommendations must 
consider the history of Canadian drug policy, alongside the growing body of evidence-based 
literature. Acknowledging this history can prevent further repetitive action – such as the 
continued implementation of prohibitionist policies – that have been essentially ineffective in 
Canada.  
Lastly, a thorough understanding of Canadian drug policy is needed to appreciate the 
findings of the current project. Due to the specific factors that have historically influenced 
Canadian drug policy, policy makers have ignored the opinions and experiences of people who 
use drugs. However, this population’s perceptions are important in this policy discussion, as an 
understanding of their views on Canada’s current and past drug policies will better inform the 
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decisions of policy makers. Nonetheless, the historical review highlighted the current 
shortcomings of Canadian drug policies and emphasized the need for consumer-informed 
research.  
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Chapter 4: Methodology  
Research Question 
There are few Canadian studies that examine how people who use drugs view drug 
policy. Given this finding, this research will explore how people who use drugs perceive 
Canadian drug policy. Specifically, this research will explore how this population feels about 
drug strategies and what they believe would be the best approach to prevent and treat substance 
addiction. The findings from this research will add to the growing body of research that 
considers the perspectives of those who are addicted to illicit substances – a population that is 
arguably the most affected by drug policy.  
The Objectives 
This research has several objectives. First, the study examines the perspectives of people 
with substance addiction and their views on drug policy. Second, this research reviews the 
history of Canadian drug policy in an effort to contextualize the current state of drug policy. 
Third, the study examines the consequences of government mandate changes on drug policy. 
Fourth, this project will analyze the perceived effects of punitive versus rehabilitative approaches 
to preventing and treating substance addictions. Lastly, the project investigates options for future 
drug policy changes that are supported by those who have experienced substance addictions. 
Sample 
The data for this research was obtained through qualitative interviews with 19 
participants. To be eligible, participants must have experienced one or more substance addictions 
and must have been 19 years of age or older at the time of the interview. 13  For the purpose of 
                                                 
13 Participants must have experienced a substance addiction, not including alcohol. While alcohol can be highly 
addictive and is viewed as a drug, it is not an illicit substance in Canada. Furthermore, while alcohol was made 
illegal for a brief period in the early 1900s, none of the participants interviewed would have experienced their 
addiction during the prohibition. Therefore, they would not have been affected by this drug policy. However, 
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recruitment, substance addiction was defined as the problematic, compulsive, and continuous use 
of a substance, such as opioids, stimulants, cannabinoids, hallucinogens, and sedatives, despite 
the negative consequences of its use.14 Participants must have been addicted to any illicit 
substance for at least six months.  
To recruit participants, a snowball sampling technique was used. Snowball sampling is a 
non-probability sampling technique where research participants recruit other participants for a 
study. Snowball sampling is used when participants are difficult to find. This particular method 
consists of two main steps: (1) identifying one or two potential participants in the population 
being studied; and, (2) asking those participants to encourage other individuals to participate in 
the study. In other words, a known potential participant was contacted by telephone and asked to 
participate in the study – this participant recruited other participants, which led to a sample size 
of 19 participants from the coastal, interior, and northern regions of BC. While the initial goal of 
the research was to interview 20 participants, saturation was reached after 19 interviews. 
Moreover, there was a natural conclusion after the 19th interview in that there were no new 
willing participants.  
The age of participants ranged from 19 to 68 years. The mean age of the sample was 46 
years, with a median age of 47 years. The sample consisted of 15 (79.0%) males and four 
(21.0%) females. Participants’ level of education varied, as five (26.3%) reported not having a 
                                                 
alcohol is illegal to those who are under the age of 19. Hence, to avoid confusion and conflict of sampling, 
participants must have been 19 years or older to participate.  
14 An addiction to any illicit drug served as a qualifier to participate in this study. An addiction to cannabis, despite 
the drug being made legal in 2018, was also included as a qualifier for this study. This is due to the fact that 
cannabis was illegal for many decades before 2018; therefore, its previously illegal nature may have negatively 
affected the participants in the sample. Additionally, it is recognized that the addictive nature of both cannabis and 
hallucinogens have been widely contended. However, despite the lower probability of becoming addicted to these 
substances, these substances can be used problematically, and were therefore included in the sample. Regardless of 
these sampling conditions, none of the participants in the sample indicated they were only addicted to cannabis or 
hallucinogens. Rather, these substances were used alongside other drugs, such as opioids and stimulants.  
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high school diploma, eight (42.1%) reported completing high school, five (26.3%) reported 
having completed college level credentials, such as a diploma or post-secondary certificate, and 
one (5.3%) reported having a university degree. A majority (78.9%) of the participants were 
employed – two were retired, one was self-employed, and one was on work disability. The 
number of years of dependence on a particular substance varied, with a range of two to 33 years. 
The mean number of years of dependence was 17.6 years, with a median of 21 years dependent.  
The first documented substance addiction was reported in 1971. At the time of the 
interviews, two participants disclosed that they were currently using illicit substances. Moreover, 
five (26.3%) reported that their addiction began before the age of 12, while nine (47.4%) 
reported that their addiction began during their teenage years (age 13 to 19), and five (26.3%) 
reported that their addiction started in adulthood.  
Almost half (47.4%) of the participants reported using all types of illicit substances, two 
(10.5%) reported using all substances but heroin, and two (10.5%) reported using only heroin 
and methamphetamines. Six (31.6%) of the participants reported using different combinations of 
substances, which included combinations of cannabis, cocaine, crack-cocaine, lysergic acid 
diethylamide (LSD), gamma-hydroxybutyrate (GHB), MDMA, and methamphetamines. Ten of 
the participants (52.6%) experienced intravenous drug use.  
All participants reported that, even after years of sobriety, they were still attending some 
type of treatment or counselling program. For example, 16 (84.2%) reported that they currently 
attend narcotics anonymous (NA) or alcoholics anonymous (AA) meetings, while three (15.8%) 
reported that they were currently attending counselling. Of these participants, two (10.5%) were 
currently on prescribed methadone and one (5.3%) accessed safe injection supplies through their 
city’s harm reduction initiatives. A majority (57.9%) reported that they had attended a residential 
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treatment centre in an effort to overcome their addiction, while four (21.1%) relied on the 12-
step program offered by NA and AA, and two (10.5%) attended counselling. Of these 
participants, four (21.1%) also used opioid agonist therapy, such as prescribed methadone or 
Suboxone.  
Table 1. Sample Demographics and Substance Use Characteristics.  
N = 19 
Gender 
Female           4 
Male            15 
 
Age 
19-29            4 
30-39            1 
40-49            6 
50-59            3 
60-68            5 
 
Level of Education 
Less than High School          5 
High School            8 
College / Vocational          5 
University           1 
 
Employment  
Employed Full/Part Time         15 
Self-Employed           1 
Retired           2 
Unable to Work due to Health        1 
 
Years Dependent on a Substance 
2-9            5 
10-19            4 
20-29            9 
30-33            1 
(continued) 
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Table 1. (Continued) 
N = 19 
Age Drug Use Began  
12 Years or Younger          5 
Between 13 and 20 Years Old        11 
Between 21 and 23 Years Old        3 
 
Substances Used 
All             9 
All Except Heroin          2 
Heroin and Methamphetamines Only        2 
Combinations (cannabis, cocaine, crack-cocaine, LSD, GHB, MDMA, and methamphetamines) 
            6 
Intravenous Drug Use 
Yes            10 
No            9 
 
Current Drug Use 
Yes            2 
No            17  
 
Current Rehabilitation Effort 
12-Step Programs          16 
One-on-One Counselling         3 
 
Method Used to Overcome Addiction 
Residential Treatment          11 
12-Step Programs          4 
One-on-One Counselling         2 
 
Research Design and Procedure 
The research design was qualitative in nature and employed the use of semi-structured 
interviews with 19 participants. The interviews took place between 30 June 2019 and 1 October 
2019. The interviews were semi-structured, meaning a formalized list of questions was not 
followed; rather, a series of open-ended questions were asked that allowed for a discussion with 
the interviewee. In particular, an interview guide was formalized that included: several 
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demographic questions; approximately eight general open-ended questions; and several word 
association prompts to organize and stimulate further discussion (see Appendix A: Interview 
Guide).  
The interviews were conducted in English, as it is the only fluent language of the 
researcher. Additionally, all interviews were conducted one-on-one. All interviews were audio 
recorded and later transcribed verbatim for data analysis. Digital audio files were transcribed by 
listening to each recording and typing into a Microsoft Word document what had been said 
during the interview. This was completed after the interview.  
Each participant was reimbursed with a $10 CAD Tim Hortons gift card for their time 
and possible travel expenses. On average, the interviews were a half hour in length, although 
they ranged from 15 minutes to one hour. Each participant was met in a location that was 
suitable and convenient for the participant, as well as safe and secure for the researcher. To 
complete the interviews, several trips were made from the coast to the interior of BC. Several 
interviews were conducted using a telephone, due to the remote location of the participant or by 
the choice of the participant (one participant felt more comfortable being interviewed by 
telephone). All participants signed and sent a copy of the consent form prior to the interview 
being conducted.  
The data collected in the in-depth, semi-structured interviews was analyzed using an 
inductive approach. An inductive approach allows for research findings to emerge from the 
frequent, dominant, or significant themes within the data, without the restraints enforced by 
structured methodologies. This approach is different from deductive methods commonly used in 
experimental and hypothesis testing in which key themes are often obscured, reframed, or left 
invisible due to the preconceptions in data collection and analysis (Thomas, 2006).  
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Applying an inductive approach to evaluate the interviews was useful for several reasons. 
First, it condensed broad and varied text into a summary format. Second, it established clear 
links between the research objectives and the research findings. Third, it helped to understand the 
main themes that emerged from the data. The analysis of the findings was an iterative process 
that was completed by the researcher alone. Microsoft Word and Microsoft Excel were used to 
organize and draw themes from the data.  
Ethical Considerations 
Ethical approval for this study was obtained from the University of the Fraser Valley’s 
(UFV) Human Ethics Research Board (see Appendix B: Certificate of Human Research Ethics 
Board Approval). The approval term was from 5 June 2019 to 4 June 2020. Participation in this 
study was completely voluntary, and participants were asked to provide informed consent prior 
to their participation (see Appendix C: Informed Consent and Consent of Participation Forms). If 
a participant withdrew from the study, they were aware that their data would not be used, and the 
interview recording would be destroyed immediately. Due to the nature of snowball sampling, 
complete anonymity was not possible; however, confidentiality was guaranteed. All possible 
measures were taken to ensure that written information could not be directly connected to any 
one participant, including the use of pseudonyms in the report.15  
To ensure that the participants’ information and identity were protected, the data was 
stored on a password-protected folder on a personal computer and only the researcher directly 
involved in this study had access to it. All identifying documents pertaining to the interviews 
were destroyed after the research was completed. Lastly, while the study did not use deceptive 
tactics, or intend to cause any physical harm to participants, some discussion topics had the 
                                                 
15 The pseudonyms used within this report were chosen by the participants of the study.  
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potential to trigger difficult or sensitive memories, which could be mentally and emotionally 
strenuous. Therefore, participants were provided with information on how to access a counsellor 
should they require additional support or debriefing.  
It should be noted that special considerations were taken for conducting research with 
individuals who have experienced substance addiction. First, steps were made to ensure the 
research relationships and interview environment were equitable as possible. Second, the right of 
the participants to make their own decisions about their lives and the degree of participation in 
the research process were respected and supported. In particular, the rights and well-being of the 
participants were privileged over the objectives of this project and the dignity of the participants 
was upheld during their portrayal. 
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Chapter 5: Findings 
General Perspectives on Canadian Drug Policy: Advancing or Archaic?  
To assess the research objectives, participants were asked about their perspectives on 
current Canadian drug laws and on current strategies being implemented in Canada. These 
strategies included harm reduction measures and abstinence-based treatment. When asked 
specifically for their perspective on Canadian drug policy in general, 13 participants shared their 
views without further prompting. Several similarities emerged from these answers, with only a 
few participant outliers.  
Only one participant response supported the current Canadian drug policy. The 
participant stated: 
I think they’re doing an ok job. I think there’s going to be some things happening in the 
future, potentially legalizing certain drugs. I’ve heard they’re trying to legalize 
pharmaceutical grade heroin for people who are addicted to that. I think they’re heading 
in the right direction, I guess. (SMc) 
 
While this viewpoint is optimistic, it reveals the support and desire for change in the Canadian 
context.  
 Some of the participants had mixed feelings on the current state of Canadian drug policy. 
One participant held the view that while Canadian drug policy has positively advanced in recent 
years, the legalization of cannabis was not a positive improvement. He stated:  
I think it’s a lot better these days. My thoughts on the legalized marijuana, I have two 
thoughts. On one end it’s kind of good, but on the other end, does it really change 
anything? It’s almost giving people more opportunity to become addicts and they’re just 
like any other person, they don’t understand what they’re consuming. They have a 
thought pattern on it, like it’s not that bad, it’s an herb, it’s grown naturally, but it’s like, 
sorry it is bad, and it will mess you up and it will just lead to other things… It comes 
down to education, you have to start when people are young, you have to change the 
culture, you have you change the idea that you’re cool because you smoke marijuana. 
You’re not cool because you smoke marijuana, you’re stupid. You’re robbing your brain, 
especially for young people. These young people that start when they’re 12, I didn’t start 
with weed until I was 19, I’m not saying I’m a superhero but it’s better than when you’re 
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12 and your brain is still forming. You’re disrupting all those neuropaths and what 
chance have you got at becoming the best you can be. (Howler)  
 
Evidently, there is fear of the long-term consequences of legalizing specific substances, such as 
cannabis, especially given the associated consequences for young people. Similarly, a second 
participant voiced his concern of the legalization of cannabis, by stating, “The legalization of pot 
to me was not a good thing, I don’t like that” (Turtle). These respondents both felt that the 
legalization of cannabis in Canada in 2018 would be detrimental for those struggling with 
substance addiction.  
 Two of the participants voiced concern over the implementation of harm reduction 
strategies when speaking about Canadian drug policy. Referencing opioid agonist therapy, such 
as methadone and Suboxone maintenance programs, Joe Blow stated:  
My overall view on them [Canadian drug policies] is that they are not working, and I 
think they need to change them. So, I don’t really know what their strategy is, but I know 
that their strategy isn’t working, and I believe that a lot of their strategies are about harm 
reduction, and personally I believe that harm reduction does not work and is not working. 
And most of the addicts that I’ve tried to help and have worked with over the past 28 
years, that have been on harm reduction [methadone and Suboxone] are using other drugs 
while they are on harm reduction, and harm reduction just enables them to use other 
drugs and to continue in their cycle of addiction. 
 
The other participant, Princess, voiced concerns about the implementation of SIFs and OPSs in 
her hometown, reporting:  
What I get in my own hometown is that they have using stations and using places, which 
I get, people are going to use, and they might as well have a safe place. But honestly, I 
think when they’re handing out free fucking needles, they’re enabling it all. And making 
this whole problem. I’m not trying to sound like a bitch against addicts, but you’re 
choosing to use. Those people that don’t want to quit are just getting free needles. So 
honestly, I think the governments just enable it and keeping this vicious cycle going 
instead of deleting it. The only thing I do agree with around this city is we’ve built 
homeless shelters. 
 
These concerns were shared by other participants when they were asked specifically about their 
views on harm reduction measures.  
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 Seven of the participants in the sample reported similar views on Canadian drug policy – 
that Canadian drug policy is both outdated and overtly harsh on those struggling with substance 
addiction. One participant, Trojan Horse, stated that “They [Canadian drug policies] need 
change, a lot of its archaic.” The theme of describing Canadian drug policy as archaic continued 
throughout multiple interviews. One participant described Canadian drug policy as “archaic” and 
then continued:  
We are trying to use jail and policing to deal with a mental, social, and economic problem 
more than anything else. It will never work. It hasn’t worked. Prohibition of alcohol 
didn’t work and our substance abuse problem in North America is getting worse and 
worse all the time. There are laws, where right now we are currently giving away needles 
for people to do illegal stuff. So, when a law says it’s illegal, if we are given a clean 
injection site, we are actually as a society saying it is legal. And our laws need to catch up 
with that. That’s what I fully believe. We will never beat this with laws. (Tank) 
 
Similarly, while not specifically using the term archaic, another participant reported:  
They’re not helpful, they’re based on the Draconian US drug war. I think we’ve had it 
wrong for a long time and even though its proven wrong we just keep it and expect 
different results. And what we’re seeing, all this rampant addiction, has been there for 
fifty years or more, there’s deadlier substances now, there’s generational addiction, and 
people think that this is the addict’s fault, some people think this, and that influences 
government policy. But if the policy changed, you’d see such a benefit in health, not only 
to the individual people but society as a whole… It’s going to take like 10 years like it 
did in Portugal of policy change and implementation of a totally different system of 
compassionate care that hasn’t been here. So, you’re not going to change 50 years of 
neglect with 1000 naloxone kits and getting everybody on methadone and then expecting 
it to be different but you’re still coming at it from a punishment model and not a 
compassionate model. Until we as a whole get our heads wrapped around that and some 
politicians dying on the sword for that, if they have to, I don’t see the policy changing. 
(Magtek158) 
 
Essentially, these participants felt that Canadian drug policy is out-dated and has relied too 
heavily on past decisions relating to Canadian drug laws and drug policy in the US.  
Several participants echoed these sentiments while also suggesting alternative solutions. 
One respondent stated:  
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I think we’re probably following the War on Drugs model too much, and in my opinion 
that’s not very effective. Downward pressure from south of the border. So, a lot of time 
legislators’ hands are tied. I think decriminalizing is a good start, so for me the cannabis 
legalization is a good start, at least to get the conversation going because I think filling 
our prison systems with addicts and people who need help, criminalizing them and giving 
them a record, I know too many people who did something as a young person and it 
follows them forever and have struggled. So, I think it needs to shift. (Ogre) 
 
Similarly, Snowman noted: 
Honestly, I don’t think when people are doing stuff to support their addiction they 
deserve to get the maximum sentences, like I don’t think that they should get away with 
it, but it should be like, I was saying, I think it’s Sweden but I could be wrong, where if 
you get arrested and you are an addict, they give you jail, treatment, school, job, and a 
place… I can’t remember the exact numbers or anything. But going back to drugs and 
doing the same thing is lowered, because they give you the tools you need and here they 
don’t.  
 
Some participants also explored the link between punishment, crime, and shame, without 
prompting. One such participant reported:  
I think that it’s a lot of punishment in it, and I don’t think that is exactly like, I don’t 
know, I don’t think that it really fixes things, you know, and I really think that a lot of it 
is dehumanizing. Just the opinions on it and you know how it’s all like, let’s put them in 
jail, let’s punish them like they are worthless. You know? So, I don’t particularly like it. 
I’m not saying that I think it should be promoted but, it shouldn’t be so like, no no no no, 
and shameful. You know? (Karma)  
 
This participant brought the dangers of criminalizing and punishing individuals experiencing 
substance addiction to the forefront, by speaking of its dehumanizing process and the outcome of 
shame.  
In general, and consistent with previous research in this area, these findings illustrate the 
differing views between the participants, despite their shared experiences (Darke & Torok, 2013; 
Lancaster et al., 2014; Lancaster et al., 2015). Notwithstanding the differences, it is clear that 
many respondents view current Canadian drug policy negatively and in need of change. Due to 
the generalized nature of the first question, participants were asked about their perspectives on 
Canadian drug laws, harm reduction strategies, and abstinence-based treatment programs.  
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To Legalize, Decriminalize, or Penalize 
Participants were asked about their views on the recent legalization of cannabis in 
Canada and whether they believed other illicit substances should be legalized or decriminalized. 
Five of the participants objected to the legalization of cannabis in Canada. Some of these 
participants noted concerns about the difficulties of enforcing laws, such as preventing 
intoxicated driving. Another participant, Con, opposed the legalization of cannabis based on his 
own experiences with the substance, stating:  
I used to smoke a lot of weed, so, I feel that I can say that when I did smoke weed, I 
wanted it to be legal, and I was like, oh it’s not that bad, but when I quit, I realized how 
much it was affecting me. So, I just think that those people are caught up in their own shit 
and they don’t really realize how much it’s actually affecting them.  
 
Comparatively, 11 of the participants supported the legalization of cannabis in Canada. 
These participants noted the benefits of using the drug. Some participants noted that cannabis use 
was less harmful than drinking alcohol. Other participants supported the legalization because of 
its health benefits to those struggling with chronic pain or certain diseases and disorders. A 
participant, who had admitted to using cannabis for health reasons, stated:  
My methadone has come down, I am off my anti-depressants, I am off my anti-
psychotics, like it [cannabis] has replaced a lot of stuff in a good way. And I don’t smoke 
all day every day. It’s not like I wake up and I’m like fuck I need one now, usually I get 
what I have to get done in the day, and then at night, I have a puff. (Snowman) 
 
This participant noted that like anything, cannabis, if used, should be used in moderation.  
Moreover, one participant reported little change since the legalization of cannabis, either 
than seeing the drug around more than before. Rusty stated: “With it being legal, I’m not sure if 
it has changed much. I haven’t noticed anything else other than you see it a lot more than you 
normally would. Other than that, I don’t think it’s hurting anything.” This supports the 
perspective that the legalization of cannabis has not resulted in increased harm to members of 
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Canadian society. These perspectives were consistent with the findings of Osborne and Fogel 
(2017), who also found that a majority of Canadian participants favoured the legalization of 
cannabis. Lastly, several others noted that the legalization of cannabis was “… a big first step” 
for Canadian drug policy. These participants reported being hopeful that the legalization of 
cannabis will lead to the legalization or decriminalization of other illicit substances in Canada.  
 Five participants opposed the legalization of cannabis, which is the same number as those 
who opposed the legalization or decriminalization of other illicit substances; however, the five 
participants in each group were different. This is because two of the participants opposed the 
legalization of cannabis yet supported the decriminalization of other illicit substances. 
Comparatively, two were against the legalization or decriminalization of other substances yet 
supported the legalization of cannabis in Canada. Only three opposed all forms of legalization 
and decriminalization for all substances, including illicit substances and cannabis. Hence, five of 
the participants reported being opposed to the legalization or decriminalization of illicit 
substances. Howler voiced concern about the effects of legalizing certain drugs, by stating:  
Just think of the mayhem that would start if you decriminalized heroin. You’d have 
people lining up for miles at wherever they dispense it. It’s bad enough the way it is now, 
they make it too easy for people now.  
 
Comparatively, many voiced their support for the government to legalize or decriminalize other 
illicit substances.  
Those who spoke of legalizing other illicit substances indicated the need for a legal and 
safe supply of heroin offered in Canada. One participant reported: 
When I went to university I looked into studies and some of the things they did, pilot 
project in England, and you know, I mean they ended up having people who are heroin 
addicts pick up their heroin every day, and go to work, and they were committed people 
of society again and contributing. And they are not kicking in your back door, or 
businesses back door to steal money, because they are getting their heroin every day and 
they just go to work like everybody else. And so, what I would like to see is the 
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government really do an in-depth study or study it more, to come up with what that is 
going to look like. You know it’s fine for the question of thinking legalization is a good 
thing, but I think we need to have more information to really go, yea that’s a good idea! 
Or I am not so sure. So, yea, a lot more information would really be needed, I mean there 
are studies, like look at Portugal, and what they’ve done. There are a lot of countries, 
Switzerland, there are a lot of countries that have done this. Will it work in Canada? I 
don’t know. Being next to a country that has Neanderthal ideas about drug addiction, 
amongst other things? But so yea, will it work in Canada? I don’t know… I think we 
need to look at it more, we need to put more money towards it and move in that direction 
of change. I just don’t know what that looks like to have it. It’s going to be regulated, but 
how is the question. So, I am for it. I mean, people are dying. (Lovern) 
 
Another participant, Centaur, added: 
If you are going to legalize one, you may as well do them all. Do the ones that are 
causing all the damage, major damage, and that’s the heroin and the crack that is being 
made and the people that are having. How stupid are they? I mean, get the drugs legalized 
and under control so that our friends, and our families, and our loved ones who are 
smoking that shit aren’t going to die from it, because it’s actually got some substantial 
drugs involved in it.  
 
The need for more research on the effects of legalizing certain illicit substances resonated with 
many of the participants.  
Another participant, Tank, anticipated how others might react to the idea of legalizing 
heroin and other illicit substances and countered it by asserting: 
I know there is a lot of worry and I hear a lot of people talk, well if we legalize, we can’t 
legalize heroin, and I’m like “why? Would you suddenly do heroin tomorrow if it was 
legal?” and besides, if we licensed it and monitored it and somebody is overdoing it, we 
could then intercede on their behalf. Right?  
 
This participant argued that legalizing heroin and other ‘hard’ drugs would not necessarily 
increase their use among the general Canadian population; instead, the legalization of these 
substances would increase the ability to monitor and help those who are using.  
 Legalizing or decriminalizing illicit substances has been an increasingly common 
approach in many countries to help reduce the harms associated with substance use. For 
example, Switzerland, the United Kingdom (UK), Germany, and the Netherlands have offered 
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prescribed heroin under medical supervision (Transform Drug Policy Foundation, 2020). Heroin-
assisted treatment (HAT) is used to treat long-term addiction to illicit opioids, with the addiction 
being unresponsive to other forms of treatment. The use of HAT has supported arguments for the 
legalization of a safe drug supply in these countries (Transform Drug Policy Foundation, 2020).  
In countries, such as Portugal, Costa Rica, the Czech Republic, the use of illicit 
substances is not punished criminally, and the possession of small amounts of the substances are 
allowed (European Monitoring Centre for Drugs and Drug Addiction [EMCDDA], 2017; 
EMCDDA, 2019). These countries have formed their own drug policies, in which illicit 
substances are decriminalized. These countries have succeeded in decreasing the spread of HIV 
and AIDS, and decreasing drug-related overdose deaths (EMCDDA, 2017; EMCDDA, 2019).  
 Many of the participants agreed with decriminalizing all illicit substances in Canada and 
implementing a medical model approach, as seen in countries such as Portugal. Although these 
arguments varied, several participants noted how decriminalizing drug use and possession would 
reduce the criminalization and the subsequent stigmatization of people who use drugs. Jesus 
argued to “… decriminalize the petty addict, the 16-year-old kid homeless on the street corner 
peddling a dime bag of blow because somebody gave it to him but penalize the guy that brought 
in the kilo.” Echoing these sentiments, another participant, Joe Blow, maintained: “I think they 
[illicit substances] should all be decriminalized. And then we should go towards a treatment 
model in society, where we are encouraging people to seek help for their problem.” While the 
participants did not necessarily support illicit drug use, they supported the idea that 
decriminalization of illicit substances could help people recover from addiction.  
A participant who eloquently explained this idea stated: 
I don’t think all drugs should be legalized, they should be decriminalized. They do a 
really go job in other parts of the world, Portugal is one example, in New York they have 
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drug courts that have taken a lot of the pressure off the courts. The majority of people 
doing drugs are not doing criminal behaviour, there’s a faction that are, and I think some 
of that driven by the policies because they’re demonized and criminalized and not 
engaged in society. That’s not going to totally go away because you decriminalize drugs 
but a large majority of it would and for the stuff that’s not, there should be consequences 
for criminal actions but separating those two things in people’s minds, criminal action 
from people who use drugs, because the use of drugs has been criminalized for so long in 
North America that people associate the two as one thing. A lot of people on the whole 
assume every homeless person must be an addict and using, or every person with mental 
health challenges must be an addict. These are some of the attitudes that have prevailed 
and helped policy lagged behind, and it doesn’t really matter which came first, the 
chicken or the egg, the criminalization and demonization of drug addicts has helped 
sustain those attitudes in society, or those attitudes have help sustain the policy, but they 
feed each other. (Magtek158)  
 
Given the negative implications and stigmatization that result from the implementation of these 
laws, the continued criminalization of drug use is viewed as harmful.  
Another participant agreed that illicit substances in Canada should be decriminalized but 
was sceptical of this becoming a reality. In summary, the participant maintained that models of 
decriminalization have been successful in other jurisdictions, such as Portugal; however, due to 
the prohibitionist nature of Canadian drug policy, he was uncertain of this model being 
successfully implemented in Canada. Despite this uncertainty, the participant was in support of 
researching and testing the idea.  
 A majority (57.9%) of the participants supported the legalization of cannabis in Canada. 
Moreover, a majority (63.3%) also supported either legalizing or decriminalizing other illicit 
substances in Canada. These findings are important to note, since decriminalizing illicit 
substances and legalizing a safe supply of heroin are both policy options being discussed in 
Canada (Angus Reid Institute, 2019; Corace et al., 2019). Moreover, due to the overall support 
for these law reform strategies, these options will be further considered and analyzed in the next 
chapter.  
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Reducing Harm: It Should be a Simple Answer, Right? 
Participants were asked to describe their views on harm reduction measures. These 
included SIFs, SCFs, OPSs, opioid agonist therapy, and naloxone kits. Perspectives among the 
participants varied, with some supporting all harm reduction measures, some supporting certain 
methods, and others not supporting harm reduction measures at all. The opposition or support for 
these strategies seemed to be largely based on the strategy’s perceived effectiveness. Moreover, 
many participants voiced uncertainty on this topic.  
 Those who opposed the use of harm reduction measures in Canada referenced their own 
experiences with substance use. Sassy stated, “From my personal experience, the injection sites, 
if there were those sites I probably would’ve used more because it was hard for me to get 
paraphernalia.” Another participant, Joe Blow, who used the term harm reduction to mean opioid 
agonist therapy, reported:  
Harm reduction measures aren’t working… most addicts that go on harm reduction are 
only using it to enable them to use other drugs, and not be dope sick, and they are using. 
If harm reduction was monitored way more closely, and if you had people who tested 
positive for any other drug while they are on harm reduction, and they were removed 
from harm reduction immediately, the abuse of that system would go away, but there’s a 
lot of financial gain and kickbacks to doctors and methadone recovery houses, and it’s all 
about money, right? Those people need to be in it more for the actual help and helping 
the addicts than the money that is involved.  
 
In this instance, the participant did not agree with the implementation of methadone and 
Suboxone maintenance programs, due to availability of other substances. Comparatively, Rusty 
commented positively on the methadone maintenance program, maintaining, “I think the harm 
reduction can be trouble at times, but I’ve also seen guys I work with come in on methadone and 
within six months can slowly ween off that and actually have long term recovery.” Evidently, 
participants have divided views on the benefits of this harm reduction measure.  
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 There was also concern about the distribution of drug paraphernalia to people who use 
drugs. These participants argued that while this practice was a positive advancement in drug 
policy, there needs to be more addictions resources offered. One participant expressed:  
Just getting them off the streets so we can’t see them doesn’t solve the problem, not even 
slightly. So, I am glad we are moving towards that, but we need to move farther so that 
we invest more in actual treatment so that when somebody says that they need help, our 
response as a society should be, “Where are you? Somebody’s coming.” Not, “We are 
putting you on a waiting list and in a month or two you’ll make it in”. That’s my belief to 
really start solving the problem, in the meantime I think that it’s good the we’re giving 
some clean needles, I just wish they had a plan to pick them up. And just handing them 
out, us junkies aren’t really known for our cleanliness. It’s not on the top of the list, right 
after you bank back a few points of heroin. (Tank) 
 
These comments reflect how the perspectives among the participants vary. Many of the 
participants formed opinions on harm reduction strategies based on their own lived experiences 
with substance addiction. Some had negative experiences with certain harm reduction strategies, 
which resulted in negative perspectives. Others understood the benefits of the strategy yet 
highlighted the strategy’s weaknesses. Regardless of these variations, the benefits of harm 
reduction strategies were contended.  
 Despite these concerns, there were several participants who indicated their support for 
harm reduction measures. Many noted the benefits of harm reduction measures, maintaining that 
they work to keep people who use drugs alive and well during a time that they may not 
necessarily be capable of quitting. AJ explained:  
I believe in every strategy to help and to minimize the effects of drugs is a good strategy. 
Harm reduction helps people sometimes to be less scared of and less imprisoned, you 
know what I mean, so in the long run it works both ways, to the government too, like less 
spending money on drugs, that they want or not, they criminalize, you know, people for 
the drugs, they spend more money on keeping them in prison, which is useless, right? 
And then when they do this harm reduction, they can have more chance to educate people 
about drugs and the rehabilitation, so it’s kind of like, in the long run, I think they can 
save more people or change a lot of lives that way, than imprisonment.  
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Another maintained that harm reduction measures are “… a step in the right direction…” and 
“… anything, be it safe injection sites and mobile clinics passing out needles, stuff like that is 
positive” (Ogre). These participants recognized the need for increased safety measures for people 
who use drugs, to avoid the spread of diseases, and to prevent overdoses and drug-related deaths. 
One participant, Karma, who has utilized harm reduction strategies in her community, stated:  
I think that it is really good that they have harm reduction, because I know that there 
would be a lot of people with HIV and stuff like that if there wasn’t harm reduction. And 
I might even have HIV if there was not harm reduction. You know? And I think that even 
the people that you know, even if there was no harm reduction, there would be people 
that get diseases, and if they become clean, they still have a disease for life. So that is 
bad, and that could spread to more people that even never were drug users. So, I think it 
helps the population, our community. 
 
This participant argued that harm reduction measures help to decrease the health risks associated 
with drug use.  
 Lastly, several participants indicated their support of the take-home naloxone kit program 
in Canada. They explained that, due to the increase in opioid-related overdoses, the need for 
naloxone has increased in recent years. Centaur explained: “The last three years I have attended a 
total of 14 different people who have overdosed, to which I have had to either pump their chest, 
or I had to inject them with Narcan.” Another participant, Rusty, similarly spoke about using a 
naloxone kit on an overdosing stranger, stating: 
Last week I actually had to bring somebody back in a Subway and it just happens that 
they had a naloxone kit on them. It’s great, there’s just not enough people that are 
educated on it, for example the workers at Subway had no idea what to do if someone 
overdosed in their store and luckily, I just happen to walk in and hit them with the 
naloxone. So, a little more education for the community would be great but I think that’s 
starting to come together too because they are doing a lot more awareness with the 
fentanyl crisis and the overdose crisis. 
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These examples illustrate how important the distribution of naloxone kits is, as they are routinely 
used to save lives. In general, the participants of this sample were conflicted in their views on 
harm reduction measures.  
All or Nothing, the Machine called Abstinence-based Treatment 
A majority of the participants viewed abstinence-based treatment positively. This is not 
surprising, given that a majority (57.9%) had attended a residential treatment centre to overcome 
their addiction, while four (21.1%) relied on the 12-step abstinence-based program offered by 
NA and AA. Additionally, 16 (84.2%) reported that they currently attend NA or AA meetings 
regularly. Consequently, 14 (73.7%) of the participants perceived a combination of a treatment 
program, counselling, and partaking in NA and AA meetings as the most effective approach. 
One participant reported: 
I think it works. I’m in an abstinence-based program and I think that works really good. I 
don’t like the other wet facility very much because they’re not helping the problem in any 
way. I think there are more recovery houses where people having a better shot at getting 
the problem fixed. The recovery house where I’m at does a great job. (SMc) 
  
The successful completion of an abstinence-based treatment program may have affected 
the policy views of the participants in this sample. Critics may argue that this diminishes the 
value of these findings; however, the study aimed to gain the insights of the participants – these 
insights being made based on the learned knowledge and lived experiences of the participants. 
While it is recognized that there may be a higher rate of support for abstinence-based treatment 
in this sample, the responses are inherently valuable. Moreover, there were several themes drawn 
from the participants’ responses.     
Though a majority of the participants supported abstinence-based treatment avenues, 
many reported the need for more available and affordable treatment options. One participant, 
Karma, who supported abstinence-based treatment, stated:  
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I think it’s unfair that they have treatment centers that you have to pay a lot of money for 
though, because, you know, not everyone can do that. Like, why do they even have 
those? But there’s a lack of treatment too. Like I know there’s not enough for everyone. 
So, you have to get on a long waitlist and that’s not always good because you might be in 
a different place in a year.  
 
Similarly, Sassy recognized the difficulties of getting admitted into affordable treatment, 
explaining, “… if you don’t have money, I don’t know how you’d get treatment, like I wouldn’t 
have ever. And there are ones where you don’t pay but there’s such waiting lists.” Moreover, 
Princess maintained that “We need cheaper rehab facilities, so people can afford to get that kind 
of help.” 
Participants also expressed the need for more treatment beds. One participant stated: 
Abstinence based treatment programs? They’re wonderful, we need more. And we need 
more free ones, not everyone can afford $13,000 a month for treatment programs. The 
government needs to look at getting people to abstain somehow to get them back 
integrated into society and feeling good about themselves. When you’ve got homeless 
people that hate life and aren’t happy it’s just a downward spiral. And then the crime that 
spews out of the addiction like the B&E’s, drug dealing, prostitution and on and on, it’s a 
plague. We need more treatment centres. (Turtle)  
 
These findings are important, as many of the participants indicated that those who are deeply 
entrenched in drug use often lack family and positive peer support or the money to afford 
immediate treatment. Subsequently, this deters those in active addiction from seeking and 
successfully completing abstinence-based treatment programs.  
 Some of the participants also indicated that while treatment programs are beneficial, they 
need to incorporate holistic healing methods. AJ explained:  
The treatment programs, in my view and in my studies, I feel like you can’t treat one 
thing without the other. Like it’s going to have to be dual treatment, like you can’t treat 
addiction without treating other parts of like, the environment, you know what I mean, 
the background, the disorders, along with the addiction. So, I think you have to be treated 
all at once in order to really beat addiction. Cause if someone, they do drugs because of 
depression, then if you don’t treat the cause of the depression, why they are depressed, 
then they will keep doing it. Like kids that grow up that are homeless, and they are 
dysfunctional, they have to steal and when they do all those things, they become 
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depressed and anxious, and live in fear, and drugs become almost like a medicine to 
function or feel comfortable, like less care. So, if you want to treat that addiction, you got 
to make sure that these people have a life worth living. Like, you know, they have access 
to education, access to a home, stuff like that, so I mean, the whole community and the 
government have to be a part of treatment, in a sense.  
 
This participant emphasized the need for treatment programs to consider and respond to the 
unique needs of every individual. This includes considering the lived experiences and past 
traumas of each patient, before creating a treatment plan for that individual.  
 Several participants noted that abstinence-based treatment programs are largely 
unsuccessful when the individual is forced to participate. Joe Blow explained, “Well treatment 
programs are wonderful, if you get the addict when they are willing to get clean…”, while 
Princess added, “Unfortunately, I think many people go to treatment that are forced to and they 
don’t really want to get treatment and they relapse right away.” Another participant, Con, who 
was not entirely in support of abstinence-based treatment programs, stated:  
I guess they kind of work, they work for people who want to do them. If you want to quit, 
then you’ll quit, but if you don’t then no one can force you to. So, they are effective for 
people who want to, or maybe if they’ve gone rock bottom or something like that, but 
otherwise, I don’t really know. They don’t seem that effective. And people don’t seem to 
really like it, the whole stigma around it where people don’t really like that sort of thing. 
 
Participants agreed that abstinence-based treatment programs are beneficial for those interested 
in overcoming their addiction; however, these programs are usually not beneficial to those 
mandated to participate.  
 Only two of the participants opposed against abstinence-based treatment programs. Both 
had experienced abstinence-based treatment in some capacity yet were sceptical of their benefits. 
Moreover, one participant, Lovern, explained the danger of a uniform approach to substance 
addiction, stating:  
I think there was this philosophy of one size fits all and there is still that mentality among 
many of the old timers in alcoholics anonymous and narcotics anonymous, that one size 
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fits all, that we are the answer. The book that I read in alcoholics anonymous says that on 
the very last page, says that we know only a little, you know? We know only a little. And 
so, I think that abstinence-based programs had their day, and it will be a good day when 
they are gone for good in that regard where we forced people to do this, abstinence-
based, no. People need choice. People need freedom to be able to decide what’s best for 
themselves. You know, there’s this idea that on one hand, that addicts can’t decide for 
themselves, and don’t, you know, all people, you, me, we know the sum total of all our 
days and I do, and you do, and we know what has worked for us in our lives and what 
hasn’t. No one else knows, but we do. And with that information we really need to 
choose, well I tried that, and it really didn’t work for me and I didn’t feel comfortable, 
well then, it’s time to look at something else. So, yea, I think these other options need to 
be even more available to people and yea, abstinence-based, I don’t know. 
 
While many of the participants had experienced abstinence-based treatment programs during 
their recovery, there were two suggestions made to improve these programs. The first suggestion 
was to increase treatment availability and affordability. The second recommendation was to 
increase treatment options that focus on each individual’s specific needs. Apart from these 
suggestions, it is evident that abstinence-based treatment programs should be entered willingly, 
as the effectiveness of the programs can be hindered by an individual’s reluctance to become and 
remain sober.  
Canadian Drug Policy: Have You Felt the Changes?  
All of the participants indicated that they felt the approaches taken by the government 
towards substance addiction have changed in Canada. Moreover, a majority (63.2%) agreed with 
the perceived changes. Many indicated that they agreed with the increase in harm reduction 
measures and low-income housing developments that have been implemented by the government 
in recent years. One participant explained:  
I haven’t been around that long, so I don’t know, but it seems like they are more like, I 
can go to interior health and get supplies, I can go to a pathways and get counselling or 
drugs that help, and there are some places that are accepting about it, whereas back in the 
day, I think it wasn’t allowed at all. I think it was so shameful and a secret. You know? 
So, I think we are coming around to accepting, not accepting it, but it being like, okay 
let’s help you not just like, you’re bad. Yea, I am glad. It’s better. (Karma) 
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While many identified and supported the changes to Canadian drug policy, many argued 
that more change was needed to address the current epidemic. Becky maintained “I think that 
they should be doing more, like, I do agree [with the changes], I just think they could be doing 
more.” Mirroring these sentiments, another participant stated: 
It’s progressed, has it progressed fast enough? You know, I guess if you talk to a mother 
or father who has just lost their son or their daughter, not quick enough. So, do I think 
that it’s a good idea? The faster that we can progress with studies and ideas and move in a 
direction towards more harm reduction and legalization, and the regulation of that, the 
better off moms and dads and their children, whoever else’s families are going to be. 
(Lovern) 
 
Additionally, a third explained:  
Yeah, it’s changing, I agree with them, there’s more talk than there is change, like there’s 
a lot of discussion. I do feel the swing starting, I think it started about 5 years ago and 
we’re about a quarter of the way into the pendulum where it needs to swing to where 
we’re really doing well, having all these resources available and treating people. 
(Magtek158) 
 
It is clear from these statements that while the recent changes in legislation and strategies are 
generally supported, there is still a need for further innovation.  
 A minority (31.6%) indicated that they did not support the changes the government has 
made in recent years. This is due to the perception that these changes had not fixed or improved 
the underlying causes of the overdose epidemic, rather these changes were viewed as addressing 
merely the symptoms of a greater problem. Moreover, those who opposed the implementation of 
harm reduction measures were also opposed to the government’s mandate in recent years. One 
such participant, Tank, asserted:  
I am seeing quite a change, I am seeing a lot more investment and a lot more political 
will to help, but I am afraid that I am seeing the approach stay much the same that is has 
been for a long time. As I say, just giving somebody a place to live so we can’t see them 
in the park and then clean needles has not worked, they are still out doing the same crime 
that they were… Drugs are not the problem, they are a symptom of an underlying 
problem and if we never deal with the actual problem, we will never get rid of the 
symptom.  
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In a sense, the participant is speaking to the inability of harm reduction strategies to address the 
root causes of substance addiction.  
Beneficial or Harmful? Punitive vs. Rehabilitative Approaches  
One objective of this study was to analyze the perceived effects of punitive versus 
rehabilitative approaches to preventing or treating substance addiction. To do this, participants 
were asked about their views on tough-on-crime and harm reduction approaches – specifically 
whether these strategies were beneficial or harmful to someone experiencing a substance 
addiction.16 
Is there Love for Tough Love? 
The participants were asked if, in their own experience, they felt tough-on-crime 
approaches were beneficial or harmful to someone experiencing a substance addiction. A 
majority (78.9%) of the participants stated that tough-on-crime approaches were harmful. 
Notably, only one supported this approach, stating “Who cares? If they are breaking the law, let 
the time suit the crime” (Centaur). Those who opposed the use of tough-on-crime approaches 
explained that punitive measures, such as harsh penalties for drug possession and use, were 
harmful to those in active addiction. These participants agreed that the criminalization of people 
who use drugs contributes to an increase in shame and stigmatization. Moreover, the participants 
seemed to agree that punitive approaches do not address the root causes of addiction and 
                                                 
16 The participants were asked their views on harm reduction approaches, since rehabilitative-based drug policy 
generally involves an emphasis on strategies aimed at reducing drug use and its harms. Treatment, programming, 
and counselling are all associated with a rehabilitative approach. Nonetheless, harm reduction strategies, such as 
SIFs, SCFs, OPSs, opioid agonist therapy, and naloxone kit programs are arguably rehabilitative in nature, as they 
serve as a stepping stone before an individual is accepting of treatment, programming, and counselling. Moreover, 
harm reduction strategies are also often used alongside treatment, programming, and counselling, as a means to 
reduce harms before an individual has fully recovered from their addiction. Essentially, harm reduction approaches 
were used to guide this interview question, since these approaches are currently being emphasized by the Canadian 
Government’s drug policy mandate, which is a mandate focused on the rehabilitation of those with substance 
addiction.  
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subsequently lead to institutionalization and further criminal behaviour. Lastly, many explained 
that while people who use drugs should not be penalized for drug possession or use, there should 
be harsh penalties for the non-addicted drug supplier.  
 When describing the negative effects of punitive measures, the participants spoke of their 
own increased shame as they became criminally entrenched. Jesus explained:  
Well when I first started using, well I started using for all sorts of stupid reasons, but 
what I found was that I was ashamed that I used, so I used to feel not ashamed, and the 
more I kept using, the more ashamed I got which meant the more I had to use. And it led 
to petty crime and theft and then the more I got punished for it, the more ashamed I 
became, so the more I kept using because I felt ashamed. So, it just compounds it, I mean, 
it makes it worse, it’s stupid. Like what, you did a bad thing, we are going to make you 
feel like shit and we’re going to alienate you from friends, family, and loved ones, we’re 
going to exile you in a corner somewhere, because the rest of the world hates you. But go 
fix yourself. So, no, it’s the worst thing you can do.  
 
This sentiment was shared with other participants in the study. For example, Becky maintained:  
At the end of the day, they are just people, they are just people like you and I, and I don’t 
think that ostracizing them because they have an addiction makes them different in any 
way, and I think that there could be different measures, so instead of criminalizing them 
and putting them in prison, they should be provided with treatment, or a recovery 
program, or something like that. As opposed to like, “You are going to jail, because you 
are addicted to heroin!”   
 
These examples indicated a negative effect associated with the criminalization of people who use 
drugs. Unfortunately, this is not the only negative outcome of utilizing punitive measures against 
this population.  
 A second theme that emerged was the fact that these measures simply do not address the 
root causes of substance addiction. One participant explained:  
I don’t think sending someone to jail because they’re a heroin addict helps the situation. 
They need treatment, they need to get to the source of their addiction. All that 
incarceration does, in my opinion, and I’ve been there, it gets you institutionalized in 
these places, you get hardened in these places. (Turtle) 
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Another participant, Magtek158, echoed these sentiments by stating that tough-on-crime 
approaches are “…harmful, completely… Obviously that hasn’t been working but people are 
wanting to punish them harder. But we should be dealing with their substance abuse, and then 
dealing with that emotional, childhood trauma, whatever is causing this and see what happens.” 
Ultimately many of the participants shared the opinion that tough-on-crime approaches neglect 
the causes of substance addiction and only address the symptoms. This results in criminalization 
and institutionalization – an outcome that is not necessarily conducive to rehabilitation.  
 A third theme that emerged was the view that tough-on-crime approaches increase 
criminal entrenchment. When responding to the benefits or harms of tough-on-crime approaches, 
Snowman asserted:  
Oh, it is definitely harmful. Like I know for sure that if I didn’t end up spending so much 
time in jail over fucking drugs, not drug charges, but stuff to do with drug related 
charges, I wouldn’t have gotten into everything else that I did, because, like, you learn so 
much. It’s pretty much university for criminals. Right? And somebody, like I agree that 
drug addiction is an illness, right? Like it’s not a choice, it’s an illness, so like, would you 
lock somebody up because they are diabetic? Or they are down-syndrome? Or like, you 
know. You don’t put them in jail. It’s not the way to deal with it. 
 
This participant was not alone in suggesting that incarceration increased their propensity to 
commit more crimes and to continue using drugs. Another participant, AJ, explained:  
I’ve been arrested for possession and for something like a very small amount, and I was 
just imprisoned for like a possession, and like, when I go to jail, like, I remember I did, in 
jail I met more criminal people and so I had more connections of criminal mentality, and 
I would sell drugs too and so I would get hooked up in that business and that lifestyle, 
and I know more connections with criminals, so it didn’t help me and I don’t think it 
helped the government either because when I go it costs a lot of money for the 
government to keep me in prison, and at the same time, it doesn’t benefit me or the 
government. 
 
These examples illustrated how incarceration can lead to increased negative peer connections 
and solidified criminal lifestyles. Ultimately, tough-on-crime approaches were not perceived as 
 76 
beneficial to those struggling with addiction, as they were perceived to increase shame and 
stigmatization, decrease the chances of rehabilitation, and increase criminal learning.  
 The last theme to emerge from this question was the agreement among participants that 
tough-on-crime approaches should be used against those who are supplying the drugs. Princess 
mentioned, “If you’re a drug dealer, you need to fucking go away and stay away. You’re 
choosing to sell hard drugs to addicts and you’re destroying lives. Those people need to be put 
away and stopped.” Another participant, Joe Blow, who agreed with this idea, stated:  
I think they [tough-on-crime approaches] are actually harmful, now, harsher penalties on 
trafficking, especially on traffickers that aren’t actually addicted to drugs, right? The 
people that are actually making money off of the misery that’s going on. See, there are 
two types of traffickers, there’s the traffickers that are making profit off of it, that don’t 
use drugs, and then there are the ones that are trafficking merely to support their 
addiction. The ones that are trafficking merely to support their addiction, giving them 
harsher penalties really isn’t helping them, it’s just allowing them to be in a different 
environment and building a network of people that are involved in the same stuff, so it 
doesn’t help the solution at all. Harsher penalties for people who are trafficking narcotics 
who are not addicted, I’d be all for that. Because in my opinion, those people are really 
scummy. Now, when you are addicted to drugs and you are selling drugs because you are 
addicted, well sometimes you are doing it because that’s what you go to do, you know? 
 
These sentiments support the view that the personal possession and use of illicit drugs 
should be decriminalized in Canada. The participants argued that if a medical model approach 
was imposed, more individuals could seek help for their substance addiction. Furthermore, they 
maintained that this option would still allow for drug traffickers to be charged and convicted of 
crimes, which they strongly supported. In general, the negative views on tough-on-crime 
approaches among the participants supported arguments for decriminalization.   
The Winner of the Least Effective Strategy Vote Goes to… 
 When participants were asked about the least effective approach in Canada, 52.6% (10) 
indicated criminalization and incarceration. Many explained that treating those with substance 
addiction would be more effective than charging, convicting, and imprisoning them. Joe Blow 
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asserted that the least effective method for handling people with substance addiction was “… 
treating them like criminals instead of treating them like people, right? Addicts are somebody’s 
son, daughter, mother, father, somebody’s child, right? We need to start treating them more like 
people.” These participants recognized that there were harms associated with the incarceration 
and criminalization of people who use drugs, which led to the belief that this option was the least 
effective for those struggling with substance addiction.17  
Strategies to Save Lives: Is it Enough? 
A majority of the participants reported that harm reduction approaches were beneficial 
for reducing drug associated harms and drug-related deaths. However, many voiced concerns 
that these strategies were merely short-term bandage solutions, failing to address the more 
important issues in Canada. Moreover, many reported that improvements are needed to the 
implementation of harm reduction strategies to ensure that a connection between harm reduction 
and treatment is made.  
 There were two participants who believed the use of harm reduction strategies were 
harmful. They both maintained that harm reduction strategies enable those who use drugs to 
continue using. One explained that harm reduction measures are “definitely harmful. I think it 
helps them out, it keeps them going like, ‘It’s not a big deal if I overdose now’” (SMc). 
Comparatively, another participant, Magtek158, stated:  
They’re obviously beneficial. We’ve seen huge cuts in overdose deaths, the last I heard 
there hasn’t been an overdose death in the Vancouver safe injection site. Even the 
handing out of clean paraphernalia, you even have some questions, like my sponsor, if 
                                                 
17 These perceptions are consistent with previous research that has illustrated the serious health and social harms of 
criminalizing individuals for using and possessing illicit substances (de Villa, 2018). Some of these recognized 
harms included: increasing negative stereotypes and stigma of those who use drugs from service providers, family 
members, and the general public; creating criminal records that hinder employment and ability to find housing; 
enhancing difficulties accessing harm reduction services; forcing individuals into unsafe spaces and high-risk 
behaviours; increasing overdose and blood-borne infections, such as HIV, hepatitis, and tuberculosis; creating an 
illegal drug market; and costing Canadian police, courts, and prisons an extra two billion dollars a year to enforce 
drug laws (de Villa, 2018). 
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you’re enabling. But when we were using people just overdosed and died because they 
didn’t get help and then you just went through their pockets for what they didn’t need 
anymore. And I asked him if he ever smoked out of a light bulb or out a tin can, did you 
ever shoot up with puddle water? Of course, he did. It didn’t change the fact if you had a 
good needle to use, nobody enabled him, and he used for 30 years. And he said, “Oh yeah 
that’s a good point”. It’s very beneficial, they’re great engagement tools, especially the 
safe use sites. Another mistake that people make is thinking people want to be using, I 
would be very shocked if 10% of the people we housed said this is the life they wanted, 
and they wanted to keep using.  
 
 Those who supported harm reduction approaches argued that harm reduction saves lives. 
Karma explained: 
I think it’s good, because some of those people, like it could be your daughter, and you 
know, if there wasn’t Narcan then your daughter could be dead. And since there is 
Narcan and she can get saved, maybe in a couple years from now, she might recover and 
become really successful and have a good life. But if there was not Narcan, she would be 
dead and not have that ability. So, I think it’s good that people can have second, third, 
fourth chances and stuff. And I think that it’s also like, some people think it’s bad 
because you know people keep getting Narcaned and they don’t change, but I think that 
it’s like, you know those people, at least they have a chance to live and change one day or 
at least they are alive. 
 
Some participants believed that these measures simply hid the problem. For example, 
some argued that the underlying issues relating to the opioid epidemic in Canada were not being 
addressed. However, they maintained that these measures were needed to reduce the associated 
harms of substance use. Therefore, harm reduction measures were viewed as a necessity, but not 
as a solution to the larger problem. 
Some of the participants supported harm reduction measures but explained that there was 
a need to connect the harm reduction strategies to further rehabilitation efforts. One participant 
recalled the time he saved an individual using naloxone. He stated: 
For me it’s just about building that relationship “Hey man, you okay from last time?” 
“Oh, that was you?” “Yeah it was, hey have something to eat.”, and then we’ll have that 
relationship. So that, as a harm reduction approach, opens up that conversation providing 
that person with follow through, if you don’t have any follow through your just turning 
into a number, yourself as a person that’s applying it, and the person you’re just 
reminding them they’re just a number or a statistic. (Trojan Horse, age 46) 
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The participants also spoke about the link between offering harm reduction programs and 
successfully admitting people into treatment programs. They argued that relationships need to be 
built between those accessing the programs and those running the programs. Ultimately, many of 
the participants believed that treatment programs should be the end goal of harm reduction 
strategies.  
Participants’ Suggestions for the Future 
Another objective of this study was to investigate options for future policy changes. The 
participants were asked to share their suggestions regarding drug laws and treatment. The options 
for legislation and strategy changes included: (1) to decriminalize all illicit substances and 
implement a medical model approach or to legalize specific substances for prescribed use; (2) to 
increase treatment program availability and affordability, along with holistic and individualized 
care practices; (3) to increase Canadian society’s awareness and knowledge of substance 
addiction to aid in reducing the stigmatization; and, (4) to increase community resources. The 
findings will be reviewed below.  
From the Streets to the Court House: Let’s Talk About It  
The most common suggestion was to decriminalize or legalize all illicit substances in the 
country. Nine participants suggested that all illicit substances in Canada be decriminalized, while 
two suggested that Canada legalize a safe supply of drugs. The two who suggested the 
legalization of illicit substances were also in favour of decriminalization but viewed legalization 
more strongly. In addition to supporting the decriminalization of illicit substances, many 
supported heavy penalties for drug traffickers. They clarified that decriminalization or 
legalization should not be a ‘free for all’ but rather a way to regulate drug use and treat substance 
addiction.  
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Ogre, who was in support of decriminalizing illicit substances in Canada stated:  
I think they’re moving towards an enlightened approach with decriminalization and I 
think that conversation needs to start with other drugs. The more they’re able to keep in 
that vein of conversation, even with harder drugs, and also stop the absolute underground, 
like grow ops were the big thing when I was young, well now government does it and 
that’s going to put a lot of that out and I think that’s a positive. I don’t see how people 
can say that’s going to cause a whole new generation of addicts because we have that 
with alcohol, we have that with cigarettes, nobody had to sit there and say I’m going to 
do it now that its legal. People are going to do what they’re going to do and they’re going 
to find an avenue for it, but I think now our path is a little more enlightened and I hope 
that we don’t regress… I think we’re moving in the right direction with 
decriminalization. 
 
Those who supported decriminalizing all illicit substances emphasized implementing a medical 
model approach. Joe Blow explained, “Medicalize it and make it readily available, right? 
Treatment needs to be readily available when an addict says I want to stop, right?”  
 Similarly, those who supported legalizing all illicit substances explained the importance 
of legalizing a safe supply of drugs to reduce the harms associated with drug use, overdoses, and 
drug-related deaths. One participant maintained:  
For me, I think you’d alleviate a lot of the problems in society if you legalized these 
drugs. I mean, it’s a choice for people, if they want to choose, they can do it safely. I 
don’t think you can influence choice, people have their own mind and choices and if they 
choose to go down a road then at least give them the proper chance. (SMc) 
 
Many of the participants also felt that these approaches would aid in the rehabilitation of those 
suffering from substance addiction. Both the decriminalization and legalization of illicit 
substances in Canada will be further explored in the discussion.  
The Elephant in the Room: Treatment Program Woes   
 The second most common suggestion was to increase the availability and affordability of 
treatment programs, while also increasing the availability of treatment programs with holistic 
and individualized care practices. The participants called for more treatment programs, as they 
argued that there are usually long waitlists to be admitted. They argued that waiting for a bed 
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was not conducive to rehabilitation, as an individual with substance addiction will typically only 
abstain from intoxicants for a short period of time. Joe Blow explained:  
So, a little bit more about my story, I was overdosing on crack cocaine pretty regularly, 
and I had epileptic seizures, so I would end up in the hospital quite regularly, and my 
doctor would say you should quit using dope, and then I would say, yea yea yea, okay, I 
will quit using, and then he would sign me up for a treatment facility, and he would say 
you have to stay clean for two weeks, and I would say yea okay, no problem, and by that 
point I just wanted out of the hospital and 20 minutes later I’d be getting high. If 
treatment had been readily available while I was at the hospital, like maybe if they had a 
treatment facility in the hospital, they could have said, hey you have a serious problem, 
we are putting you in this treatment facility. 
 
 The participants understood that those who qualified for welfare in BC, also qualified for 
a subsidy from the BC Government to attend a treatment program without fees. However, they 
stated that those who were able to pay the $10,000 or more to attend a treatment program were 
more likely to be admitted sooner than those who were subsidized. In response, Rusty stated, 
“…it doesn’t matter if you’re loaded or poor as can be, addictions going to get you and the 
biggest problem is accessing treatment for those that don’t have the funds to put themselves 
through long term recovery.” Similarly, another Turtle argued for:  
More treatment facilities that are free. Not everybody can afford these private treatment 
centres, they’re all over BC but not everybody has $13,000 to stay in one tomorrow, and 
some of these people stay in there for three months and there forty some thousand dollars. 
The government needs to get more of that kind of thing going and make it more available 
for everybody.   
 
 Lastly, two of the participants called for a change to the design and delivery of treatment 
programs. They explained that not all people with substance addiction are the same; therefore, 
their treatment needs will be different. Lovern explained:  
I just think that there are many approaches and that is what we have to entertain, and 
what we have to look at for people, because not everybody is a cookie cutter cut type of 
deal. And that’s what we’ve been working from in the past, cookie cutter. We are all the 
same right? No, we are not. You know? My life is not the same as the guy who sat beside 
me in a meeting. My life is not like his today.  
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With a similar perspective, the second participant, Ogre, stated, “I know to do that 
[individualized treatment] it takes funding and changing a whole system and attitude, but ideally, 
I think that, multi-pronged with nutrition, with environment, with people’s education, poverty 
level, I know those all factor in.” In general, these participants acknowledged the need for 
treatment programs that account for the unique experiences of each patient. Additionally, they 
recognized potential difficulties with implementing these ideas, due to limited funding and 
effecting system-wide change. Regardless of these concerns, these suggestions are worth more 
analysis.  
Education to End Stigma 
The third most suggested recommendation was to decrease stigma by increasing the 
public’s education. Six participants stated the need to reduce stigmatization. One suggestion was 
to educate Canadians about substance addiction. For example, when speaking of the need for 
more knowledge on substance use and addiction, Centaur, explained, “I would start talking to 
kids at the earliest age that you could, and I would make that a part of their curriculum in 
school”. This participant explained that education would inform children of the reality of 
substance addiction. Snowman also stated that people should be “… getting out there with 
knowledge.” In other words, he suggested that information on addiction be more readily 
available and distributed to members of the public. These suggestions have the potential to 
reduce the stigmatization of those who use drugs.  
 Throughout the interviews, many participants spoke about their own experiences with 
stigmatization. This was an interesting theme, since the participants were not asked about this. 
One participant commented on the stigmatization and the need for more education by stating: 
It’s like, that’s why people end up hiding it, or being dishonest, they can’t tell even their 
own family members because of fear of being judged or discriminated, you know, 
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rejected. So, they don’t say anything and that’s our view. Our perception of addiction, the 
more we change it, I think it will make a huge difference, because then people will be 
open about it, and when they are open about it they have a chance to make a right 
decision. But out of fear, your paranoia, like you lose… you are not calm enough to make 
the recognition, you are kind of confused. And you have no one to talk to. The people 
you care about and love, you can’t tell them. (AJ)  
 
Another participant, Con, argued that an ideal approach to substance use and addiction 
would be to reduce stigmatization so that “… maybe you will feel yourself as an equal rather 
than as a less. So, that’s probably like a lot of it, so many of these people feel as if, and they are 
also treated like they are less than a person, so they almost feel like they are not people, which is 
unfortunate.” This participant’s comment emphasized the desire to live in a society that does not 
stigmatize and discriminate against those who use drugs. To address stigmatization, the 
participants repeatedly emphasized the need for more knowledge and education on this disease.  
Keep the Resources Coming 
The final suggestion was to continue increasing resources for those struggling with 
substance addiction. For instance, four participants suggested the ongoing availability of 
resources in Canada for people who use drugs, such as SIFs, SCFs, OPSs, take-home naloxone 
kit programs, and opioid agonist therapies. Additionally, it was suggested that more funding be 
made available for housing placements, including the housing first initiatives – also known as 
wet houses. Karma explained that her ideal approach to substance use and addiction would be:  
Giving them a chance and getting to know them and giving them some things in life so at 
least they have a bed to sleep on, you know, so they can feel a bit more like a normal 
person in society. And then at least they can get a job, they have a place to shower and 
sleep at night, you know? So, I think they should just like, humanize them a bit more.  
 
Moreover, many of these participants also felt that resources are helpful in treating 
substance addiction. One participant, Tank, stated: 
Yea, throwing more into really helping the people, some of what we do is just sort of, 
“well if they are not in the park and we can’t see them, well I don’t have a problem in 
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town”. And I know that is not everybody, like many people are really trying to help these 
people and I am not trying to belittle that or downplay it, I appreciate what they are 
doing, but we really need to help them get to the core [of their addiction]. 
 
The participants emphasized the need for resources to support people who use drugs, to reduce 
the harms associated with substance use, and to limit drug-related overdoses. These suggestions 
are not to say that the current resources implemented have not been beneficial. Rather, this 
finding is shared as a way to emphasize the need and want for these resources – with a hope that 
these supports will continue to increase in availability and accessibility over time.  
  
 85 
Chapter 6: Discussion and Analysis 
Theme One: Decriminalizing Drug Use 
A theme that emerged from the findings was the support for decriminalizing all illicit 
substances in Canada. The decriminalization of illicit substances is the implementation of non-
criminal responses, such as fines and warnings, for designated activities, including possession of 
small quantities of a controlled substance (Jesseman & Payer, 2018). Decriminalization does not 
mean that the substance is legal and regulated, as cannabis is in Canada. 
When the participants were asked about their thoughts on legalizing or decriminalizing 
illicit substances in Canada, a majority (63.3%) supported such drug law reforms. Of these 
participants, 10 supported the decriminalization of all illicit substances. Additionally, when 
asked about their preferences regarding drug laws and treatment approaches, nine participants 
suggested that all illicit substances in Canada be decriminalized. Essentially, the findings showed 
that a majority of participants not only supported decriminalizing illicit substances in Canada, 
but also believed that this should be a priority for Canadian drug law reform. 
Those who supported decriminalizing all illicit substances commented on the perceived 
benefits and concerns about this legislative change. Participants argued that a medical model 
approach would be most effective in assisting and rehabilitating those with substance addiction. 
Moreover, several participants noted how decriminalizing drug use and possession could help 
reduce the criminalization and stigmatization of people who use drugs. While participants agreed 
that illicit substances should be decriminalized in Canada, they questioned the likelihood of this 
change.  
These findings were consistent with previous research. Greer and Ritter (2019) found that 
decriminalization was supported by a majority of the participants. Similar to the current study, 
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Greer and Ritter (2019) also found that many of the participants believed that drug laws were 
unlikely to change, due to negative public opinion. Evidently, the support for decriminalization 
among those with substance addiction is not unique to the current study, nor are the concerns 
regarding the fulfilment of this law reform.  
Due to the growing opioid epidemic, support for the decriminalization of illicit 
substances in Canada has grown among health officials and advocates in recent years (Corace et 
al., 2019; de Villa, 2018; Lavalley et al., 2018; van der Meulen et al., 2018; Vashishtha, Mittal, 
& Werb, 2017; Virani & Haines-Saah, 2020). A report by the Medical Officer of Health at 
Toronto Public Health (TPH) identified several themes that support drug decriminalization (de 
Villa, 2018). TPH conducted interviews and surveys with the general public and with those who 
had experienced substance addiction. They found that those who supported legal reform 
emphasized the need for a public heath approach to illicit substances, rather than a criminal 
approach (de Villa, 2018). Two recommendations were made, including the decriminalization of 
illicit substances for personal use and the creation of a task force that includes people who use 
drugs and policy makers to explore future options (de Villa, 2018). Overall, this report illustrated 
the support for decriminalization among those who use drugs, the general public, and the TPH.  
Several other organizations and researchers in Canada have called for the 
decriminalization of illicit substances. Henry (2019), the Provincial Health Officer of BC, 
recommended that the Province of BC “… urgently move to decriminalize people who possess 
controlled substances for personal use” (p. 5). Jesseman and Payer (2018) argued for 
decriminalization on behalf of the Canadian Centre on Substance Use and Addiction, while 
Corace et al. (2019) recommended the same legal reform model in their position paper for the 
Canadian Psychological Association. Virani and Haines-Saah (2020) recognized the need for 
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drug law reform in Canada due to increasing harms associated with drug use, and also suggested 
decriminalization as a viable option. Similarly, Vashishtha et al. (2017) argued that policies of 
drug decriminalization should be considered in North America in efforts to manage the current 
opioid epidemic. Despite the increasing support in Canada, this model is not on the agenda of the 
present Federal Government (Strike & Watson, 2019).18  
While the current Federal Government has not made it a priority to decriminalize all 
illicit substances in Canada, it is imperative to understand and assess the policies of 
decriminalization in other jurisdictions. One model of decriminalization that was repeatedly 
referenced by the participants in this study was that implemented by Portugal in 2001 (Hughes & 
Stevens, 2010).19 Under this model, drug use and possession of substances under a specific limit 
are not criminal offences, rather these acts are administrative.20 As such, new offences under 
these laws are sanctioned through specially devised Commissions for the Dissuasion of Drug 
Addiction (CDTs; Hughes & Stevens, 2010).21  
Hughes and Stevens (2010) conducted a study a decade later and found several key 
themes. While some critics have argued that decriminalization would increase drug use, Hughes 
                                                 
18 The list presented is not an exhaustive list of those who support decriminalization in Canada. Other organizations 
that support drug decriminalization include: the Canadian Association of People 
Who Use Drugs; the Canadian HIV/AIDS Legal Network; the Canadian Public Health Association; the Canadian 
Drug Policy Coalition; the Canadian Mental Health Association, among others (Henry, 2019).  
19 In the late 1980s and 1990s, rates of infectious diseases, such as HIV, AIDS, tuberculosis, hepatitis B and 
hepatitis C, increased exponentially among Portugal’s intravenous drug using population. Drug-related deaths also 
increased in Portugal during this period, with 369 deaths in 1999, which was an increase of 57% since 1997. 
Additionally, similar to current Canadian concerns, there was a growing perception in Portugal that the 
criminalization of drug use and possession contributed to drug-associated harms and the social exclusion and 
marginalization of people who use drugs. It was in this context that a government-appointed expert commission 
proposed to decriminalize illicit substances for personal use (Hughes & Stevens, 2010). 
20 Use and possession of all illicit substances of up to ten days’ worth of a drug. The amount in practice is 0.1 grams 
(g) heroin, 0.1g MDMA, 0.1g amphetamines, 0.2g cocaine or 2.5g cannabis (Hughes & Stevens, 2010). 
21 CDTs are comprised of lawyers, social workers, and medical professionals. The CDTs work with the alleged 
offender to address their drug use. The goal of these teams is to promote rehabilitation and treatment for those who 
they determine to be dependent on drugs. CDTs can impose various penalties to those that are caught using or 
possessing substances, including community work service, fines, suspensions on professional licences, and bans on 
attending designated places. For those who they determined are dependent on a substance, CDTs can recommend a 
person enters treatment or education program (Hughes & Stevens, 2010).  
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and Stevens (2010) found only small increases in reported illicit drug use amongst adults.22 More 
importantly, they found that since 2003, there was a reduction in illicit drug use among people 
who have substance addiction and adolescents. Additionally, they found a reduced number of 
drug offenders within the criminal justice system, an increased uptake of drug treatment, a 
reduction in opioid-related death and infectious diseases, and an increase in the amount of illicit 
substances seized by authorities (Hughes & Stevens, 2010). While it is difficult to assess whether 
these trends are the result of the decriminalization of illicit substances, the Portuguese approach 
is considered a model of best practices (Henry, 2019).  
Other models of decriminalization include those imposed by Costa Rica, the Czech 
Republic, and Mexico. The General Health Law of Costa Rica prohibits the personal use of 
narcotics and other drugs but does not penalize those who violate the prohibition; instead, fines 
may be imposed for the consumption of unauthorized substances in public places (Torres, 2016). 
In the Czech Republic, one can be criminally charged for producing and distributing illicit 
substances and for possessing an amount “larger than small” (Torres, 2016, p. 13).23 The 
possession of illicit substances for personal use in small amounts is not a criminal offence, but 
rather a misdemeanor subject to a monetary fine (Torres, 2016).  
In Mexico, possession of specific narcotics under a certain quantity are not criminally 
punishable, provided that such possession takes place outside of certain places, such as 
educational institutions and prisons.24 Those who are found in possession of the specific 
                                                 
22 This is a trend that was also observed in both Spain and Italy – two regions that did not decriminalize illicit 
substances. 
23 The Supreme Court of the Czech Republic decriminalized the possession of 1.5g of methamphetamine, 1.5g of 
heroin, 1g of cocaine, 10g of cannabis dry matter, 5 units of MDMA, and 5g of hashish (Torres, 2016).  
24 The following narcotics are those listed as not criminally punishable if possessed under a certain quantity: Opium, 
2g; heroin or diacetylmorphine, 50 mg; cannabis, 5g; cocaine, 500mg; LSD, 0.015 mg; 
methylenedioxyamphetamine, 40mg; MDMA, 40 mg; and methamphetamines, 40mg (Torres, 2016).  
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narcotics in quantities at or below the designated amounts must be referred to addiction treatment 
programs (Torres, 2016). The policy underlying the change in drug legislation was that people 
who use drugs should not be treated as criminals, but rather as individuals suffering from 
addiction – making problematic drug use a public health problem rather than a criminal issue 
(Torres, 2016). While this is not an exhaustive list of countries that have decriminalized illicit 
substances, it illustrates the differing policy and laws in each jurisdiction.  
The findings of the current study align with the findings of several organizations and 
researchers in Canada, who have recommended the decriminalization and implementation of a 
medical model approach. It is important to note that the participants in the current study did not 
support drug use by advocating for decriminalization, rather they wished to reduce the associated 
harms. Ultimately, decriminalization is viewed as a method of harm reduction, and a way to 
promote rehabilitation for those suffering from substance addiction.  
Theme Two: Saving Lives by Legalizing a Safe Supply  
The second theme identified was the support for a legalized and regulated supply of illicit 
substances. The legalization of illicit substances occurs when the criminal sanctions are removed. 
Often regulatory controls are implemented, as in the case of alcohol, tobacco, and cannabis in 
Canada (Jesseman & Payer, 2018). As noted earlier, a majority (63.3%) of the respondents 
supported the legalization or decriminalization of illicit substances in Canada. While only two of 
the participants explicitly voiced their support for a legalized drug supply, many of those who 
supported decriminalization were also supportive of legalization.  
Those who supported the legalization of illicit substances emphasized the need for 
stringent regulation. They argued that government regulation could provide a source of revenue 
for the country, decrease the power of the current illicit international drug market, and allow 
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those who use drugs to access a safe supply of these substances. Participants also voiced the need 
for a drug policy that would reduce drug-related harms. Ultimately, the participants felt that 
legalizing and regulating illicit substances could help reduce the effects of the opioid crisis and 
aid those struggling with substance addiction.  
Several other studies found support for the legalization of illicit substances. Similar to the 
current study, Greer and Ritter (2019) found strong support for cannabis legalization. 
Additionally, they found that the participants’ support for legalization was contingent on the 
regulation of the substances, which was similar to the views of the participants in the current 
study. Greer and Ritter (2019) also found that participants believed the legalization of illicit 
substances would hinder the illicit drug market. Participants in both the current study and in the 
study by Greer and Ritter (2019) supported the legalization of prescription heroin. 
Comparatively, Lancaster et al. (2013) found that, among those who use and inject drugs, the 
highest level of support for legalization was for cannabis and heroin, while over half of this 
population opposed the legalization of methamphetamine, MDMA, and cocaine. These studies 
show the divergent views regarding the legalization of illicit drugs, which supports the need for 
further analysis of this policy option in Canada.  
The legalization of illicit substances, and their subsequent regulation, has been a 
contended topic in Canada recently. The term ‘safe supply’ has been used to describe the model 
being promoted by several stakeholders in this jurisdiction. Safe supply refers to a legal and 
medically regulated supply of specific illicit substances (Canadian Association of People who 
Use Drugs [CAPUD], 2019).25 Those who support the legalization of a safe supply contend that 
this model is an element of harm reduction (CAPUD, 2019). While cannabis was legalized and 
                                                 
25 The illicit substances included in this definition are: heroin, stimulants such as cocaine and crystal 
methamphetamine, hallucinogens such as MDMA and LSD, and cannabis.  
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regulated by the Federal Government in 2018, the push for a legalized safe supply of heroin and 
other more serious illicit substances stems from the current opioid epidemic and the need to save 
lives (CAPUD, 2019).  
CAPUD is not the only organization that has promoted this legislative change in recent 
years. The BC Centre on Substance Use (BCCSU; 2019) has also reported that this option should 
be considered to address the ongoing opioid crisis. The BCCSU (2019) argued that, from an 
evidence-based public policy perspective, the contamination of fentanyl in illicit substances is a 
predictable consequence of drug prohibition. Moreover, they argued that the prohibition of drugs 
continues to contribute to a range of health and social consequences (BCCSU, 2019). Hence, 
they argued that a legalized and regulated safe supply of heroin and other illicit drugs would 
reduce the harms associated with people using contaminated substances. They maintained that 
while illicit substances are prohibited, the illicit drug market will thrive, and organized crime 
groups will profit (BCCSU, 2019).  
In July 2019, Vancouver City Council approved the Safe Supply Statement – a document 
made in collaboration with the Vancouver Community Action Team (VCAT). The Safe Supply 
Statement acknowledged the need for further collaboration with other government partners, such 
as the Government of Canada, to advocate for access to a regulated drug supply (City of 
Vancouver, 2019). This document further argued that a legalized and regulated drug supply was 
needed to reduce the harms associated with the current opioid epidemic. Those who have 
supported the legalization and regulation of illicit substances have maintained that these drugs 
could be supplied through various avenues, including: SCFs; doctor’s offices; pharmacies; and 
vending machines (Proctor, 2019).  
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In December 2019, the City of Vancouver unveiled an innovative experiment to fight the 
current overdose epidemic. The initiative – based in Vancouver’s DTES – is a pilot of the 
MySafe Project and is the world’s first biometric opioid vending machine (Little, 2020). This 
project allows those who are registered as opioid dependent to access a controlled and prescribed 
quantity of a heroin-alternative called hydromorphone on a pre-determined schedule (Little, 
2020). The goal of this project is to reduce the harms associated with contaminated drug use, and 
to allow those dependent on heroin a chance to stabilize their lives (Little, 2020). While this 
project does not dispense heroin or other illicit substances, it can be seen as support for the 
legalization and regulation of illicit substances.  
Although the success of an intervention will depend on the individual and their specific 
characteristics, evidence has shown that those with substance addiction are likely to benefit from 
safe supply treatment options (CAPUD, 2019). Perneger, Giner, del Rio, and Mino (1998) 
conducted a study in Switzerland on the effects of prescribed heroin for individuals addicted to 
intravenous heroin. The experimental group in their study received a median of 480mg of heroin 
daily, while the control group received none. Perneger et al. (1998) found significant 
improvements in the health scores of the experimental group, including better mental health and 
social functioning, and significant reductions in criminality, such as fewer drug and property 
related offences. These authors concluded that a heroin maintenance programme is a feasible and 
clinically effective treatment for people who use heroin (Perneger, 1998). 
Similar research on heroin maintenance has been conducted in the Netherlands, 
Germany, Spain, Canada, and in England (Uchtenhagen, 2011). Based on the unanimously 
positive outcomes of these trials, heroin maintenance has become a routine treatment option in 
Switzerland, the Netherlands, Germany, England, and Denmark (Uchtenhagen, 2011). These 
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studies noted the positive outcomes of heroin maintenance programs, and they contribute to the 
support for a legalized and medically regulated supply of illicit substances.  
Theme Three: Re-hashing Old Ways – Bringing Treatment into the 2020s  
The third theme that emerged from the findings related to treatment programming for 
addictions. While a majority of the participants in the sample viewed abstinence-based treatment 
positively, many reported the need for more available and affordable treatment. Additionally, 
several participants indicated the need for a modernization of traditional addiction treatment 
practices. The support for abstinence-based treatment was not surprising, since a majority 
(57.9%) had attended a residential treatment centre in order to overcome their addiction, while 
four (21.1%) relied on the 12-step abstinence-based program offered by NA and AA. 
Additionally, 16 (84.2%) of the participants reported that they currently attend NA or AA 
meetings regularly. Consequently, 14 (73.7%) perceived the most effective approach for those 
struggling with substance addiction is a combination of a treatment program, counselling, and 
partaking in NA or AA meetings. 
Despite this support, many participants indicated a need for change in regard to 
addictions treatment options, particularly treatment availability. They argued that when an 
individual is ready and willing to enter treatment, there should be a bed space available. The 
participants argued that, in general, there are long waits for treatment centres, which is 
detrimental to those who have recently detoxed and are ready to begin treatment. They argued 
that those who are forced to wait unfortunately return to using illicit substances. Moreover, the 
participants argued that many people who use drugs cannot afford immediate treatment, and 
often rely on assistance from the Provincial Government. They argued that those who can afford 
to pay for treatment often enter treatment sooner, while those who are subsidized by the 
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government are made to wait. This supports the need for more affordable residential treatment 
options.  
Some of the participants also indicated that while treatment programs are beneficial, they 
need to incorporate modern and holistic healing methods. These participants emphasized that 
treatment programs should consider and respond to the unique needs of every individual seeking 
treatment. This includes considering the lived experiences and past traumas of each patient. 
Moreover, several participants argued that abstinence-based treatment programs would be 
unsuccessful if an individual is forced into them. In other words, those who enter willingly will 
have better chances of success. Essentially, these participants understood that traditional 
treatment programs are beneficial for some individuals; however, they argued that treatment 
programs should take a modernized, individualized, and compassionate approach to substance 
addiction recovery.  
Similar to these findings, Fischer et al. (2002) found that all the participants in their study 
strongly expressed the necessity for choice and freedom in the design and course of their 
treatment. Moreover, Neale et al. (2015) found that many of those interviewed in their study 
displayed frustration with service providers, due to their failure to consider the unique and 
complex needs of people who use drugs and their status as part of a vulnerable population. The 
findings of the current study are consistent with previous research, in that many who have 
experienced drug use and substance addiction support an individualized treatment approach. 
Additionally, they recognized that while traditional treatment options are valuable and effective 
for some, there is a growing need for alternative treatment options.  
Although there are various reasons why certain individuals suffer from substance 
addiction, predominant addiction and treatment models have, until recently, remained entrenched 
 95 
in approaches from the 1930s (Major, 2019). Historically, western culture and drug laws focused 
on the notion that drugs are intrinsically bad and should be prohibited. This has led to the 
continued prohibition of illicit substances in Canada and the support for abstinence-based 
treatment programming.  
The work of 12-step based recovery organizations are well known throughout North 
America, yet these programs, such as AA and NA, were first developed in the 1930s (Major, 
2019).26 AA, NA, and other fellowships have their advantages: membership is free; relationships 
and support can be easily formed; and role-modelling can be very supportive. Many treatment 
and recovery centres focus on abstinence and use variations of the 12-step program. While this 
approach has been successful for many struggling with substance addiction, particularly those in 
the current study, the appeals for more holistic and individualized treatment alternatives need to 
be recognized.  
Several medical professionals, organizations, and substance addiction specialists have 
argued for an individualized and compassionate approach to addiction treatment. Volkow (2018) 
argued that designing an effective treatment program is challenging. She maintained that 
effective treatment programs should target the individual aspects of the illness and its 
consequences. Additionally, she argued that substance addiction treatment must aid the 
individual in quitting their substance use, maintaining sobriety, and achieving a positive family, 
work, and social life (Volkow, 2018). She explained that individuals with substance addiction 
require long-term or repeated episodes of individualized care to achieve the ultimate goal of 
sustained abstinence and recovery.  
                                                 
26 The goal of these programs is total abstinence – and members are taught that recovery can begin once the 
substance use has ended. 
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Maté (2009) argued that the addiction process is characterized by neurological and 
psychological malfunctions in the human brain, in which the ‘damage’ varies in severity. He 
asserted that these malfunctions are caused by the complex interactions between human beings 
and their environment. For example, an early childhood traumatic event may affect an 
individual’s predisposition to developing an addiction. Essentially, Maté (2009) argued that an 
individual’s susceptibility to addiction is created by negative in-utero and childhood experiences 
and by experiences of social dislocation.27  
As a result, Maté (2009) maintained that individualized, compassionate, and holistic 
approaches need to be considered when treating addiction. Moreover, apart from promoting 
decriminalization and the implementation of a safe drug supply, he supported methods of 
treatment that are not solely abstinence-based. For example, while abstinence may work for 
some, others may need to access opioid agonist therapy or a safe supply to work towards a full 
recovery. Essentially, Maté (2009) argued that understanding the circumstances that lead to 
addiction are essential for implementing change.  
Similarly, BCCSU (2018) recognized the need for a tailored treatment approach. BCCSU 
(2018) argued that those with substance addiction should be aware of the variety of recovery-
oriented services, addiction treatments, and harm reductions options that are available in their 
jurisdiction. They argued that those with addiction should have access to an appropriate type and 
stage of service and care, based on their illness status and personal strengths, choices, and goals 
(BCCSU, 2018). 
                                                 
27 Social dislocation, as described by Maté (2009), is when a group of human beings are torn from their cultures and 
individual identities. Social dislocation can affect those who are physically displaced, such as Native Africans 
during the Trans-Atlantic slave trade, or those who have their cultures dissolved around them, such as the North 
American Indigenous Peoples or Australian Aborigines.   
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Likewise, the National Center on Addiction and Substance Abuse at Columbia University 
(CASA Columbia; 2012) recognized the importance of tailored interventions and treatment for 
those with substance addiction. They argued that addictions treatment needs to suit the particular 
stage and severity of the addiction, the individual’s overall health status, past treatments, and any 
other personal characteristics and life circumstances that might affect their outcomes in treatment 
(CASA Columbia, 2012). Overall, there are changing perceptions of what constitutes effective 
addictions treatment. As such, there is support for programs that promotes individualized 
treatment alternatives and the use of medications, such as methadone and Suboxone, to support 
recovery (McCarty, 2019).  
Theme Four: Stigmatization and the Need for Education  
The final theme that emerged from the data was the concerns regarding the stigmatization 
of people who use drugs. When asked about their ideal approach to substance use and addiction, 
six participants stated that the stigmatization of those who use drugs needed to be reduced or 
eliminated. More generally, 15 (78.9%) of the participants voiced concerns about the 
stigmatization of this population during their interviews. This theme was a significant discovery, 
as the research questions did not ask about nor mention stigmatization. Thus, this theme emerged 
entirely on its own, without prompting.  
The participants explained their experiences of being stigmatized and noted the barriers 
created by stigma. They argued that the stigmatization of those who use drugs by medical 
professionals, criminal justice personnel, and the general public serve as an obstacle to recovery. 
They stated that the judgements and discrimination by others increased their own shame of their 
addiction, and subsequently decreased their ability and willingness to access the necessary 
resources.  
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The participants further explained that a change in society’s beliefs was needed to reduce 
the stigmatization of this population. They argued that more education on substance addiction 
should be disseminated among the general public and medical professionals. They maintained 
that people should understand addiction as an illness, rather than as a criminal trait. The 
participants argued that a greater understanding of substance addiction would decrease the 
stigmatization and discrimination of those who use drugs, as a better understanding of their 
condition would be known. Moreover, they maintained that further education for medical 
practitioners was needed, as they continue to be stigmatized in the medical system. Overall, a 
majority voiced their concerns regarding the stigmatization of this population and suggested 
more education on substance addiction be distributed among all Canadians.  
There is a growing body of literature that acknowledges the stigmatization of people who 
use drugs. A review of this literature found highly stigmatizing views of this population among 
the general public, health professionals, pharmacy staff, police officers, and those who use drugs 
themselves (Lloyd, 2013). Lloyd (2013) concluded that the stigma associated with problematic 
drug use reflects wider public fears about illicit drug use in general. He argued that the rationale 
behind the fear of illicit drugs is complex but is often derived from the social history of the 
drugs, negative media attention, political rhetoric, and the fact that many illicit drugs are 
unfamiliar and poorly understood by the general population. These perceptions have led to 
people who use drugs being stereotyped as dangerous, dirty, and blameworthy for their illness 
(Corrigan et al., 2009; Lloyd, 2013). Moreover, AIVL (2011) argued that this stigmatization 
creates barriers to health care and other resources for individuals who use drugs, which 
ultimately affects their overall health outcomes. Overall, the current study’s findings are 
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consistent with other literature that has focused on the stigmatization and discrimination of 
people who use drugs.  
These findings are also consistent with the theories of Goffman (1963), Lemert (1951), 
and Braithwaite (1989). These theories were reviewed in an effort to connect the stigmatization 
of those who use drugs to their subsequent discrimination from informing research and policy. 
Goffman (1963) explained the societal reaction to people who use drugs, and their subsequent 
social stigmatization. Lemert’s (1951) concepts supported the criminalization process of these 
individuals, by illustrating how societal reactions to drug use have led to the stigmatization and 
criminalization.  
Likewise, Braithwaite’s (1989) stigmatized shaming also helped to explain how 
stigmatization leads to increased or continued drug use among people with substance addiction. 
Braithwaite (1989) differs from Goffman (1963) and Lemert (1951) in that he considered both 
reintegrative and disintegrative, or stigmatized, shaming. Essentially, according to this theory, 
criminalizing and increasing punitive measures against those who use drugs, with no options for 
healthy reintegration, will only exacerbate their situations. 
Based on the review of the literature, it is evident that those who use drugs experience 
stigmatization and discrimination from being labelled deviant and criminal by Canadian society. 
It is also clear that the stigmatization of particular groups will lead to further deviance and 
criminality. This has created an environment that negatively effects the ability and willingness of 
those who use drugs to access treatment programs or other addictions resources. Moreover, the 
stigmatized perception of this population decreases the perceived value of their knowledge and 
lived experiences. Additionally, it could be argued that the continued discrimination of this 
population has negatively impacted their influence on policy development. Nonetheless, 
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acknowledging the lived experiences and knowledge of those who have experienced drug use 
and addiction is the first step to reducing this stigma. 
Amidst the current opioid overdose epidemic, the Canadian Government has 
acknowledged the existing stigmatization surrounding substance use. The Government has 
recognized that stigma can have an immense effect on the quality of life of those who use drugs 
(Government of Canada, 2020). The Government further acknowledged that the stigmatization 
of those who use drugs creates barriers to accessing resources and reduces the quality of care 
they receive from the health system. The Government created a public service announcement 
(PSA) that outlines the steps to reduce the stigmatization of those who use substances 
(Government of Canada, 2020). This PSA emphasized the need for education on substance 
addiction and the need to treat those who use substances with respect, compassion, and care. 
Essentially, the Government believes that the stigmatization of those who use drugs can be 
reduced by increasing awareness and knowledge and encouraging people to model non-
stigmatizing behaviour.  
Throughout other jurisdictions, educational programs have been implemented to reduce 
the public stigmatization of people who use drugs (Witte, Schroeder, & Hackman, 2018). The 
programs have included education factsheets, handouts with positive stories of individuals in 
recovery, and other types of programs. Some comprehensive programs have been offered to pre-
professionals, such as nursing students or medical students, to reduce the stigmatization of 
people who use drugs among these populations (Witte et al., 2018). The goal of these programs 
is to increase the awareness of and knowledge on substance addiction and to humanize this 
disease.  
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Witte et al. (2018) investigated the potential effects of a semester-long undergraduate 
addiction studies course on college students’ stigmatizing attitudes toward those with substance 
addiction. While their findings did not draw statistically significant results, those who were 
enrolled in the course reported more familiarity with individuals in recovery and were more 
willing to interact with these individuals than the control groups tested. These findings, however, 
were not seen as a direct effect of the course.  
Crapanzano, Vath, and Fisher (2014) aimed to reduce stigmatizing attitudes of graduate 
health care professional students by implementing an innovative curriculum combining multiple 
teaching methods. While post-intervention scores for views regarding heroin significantly 
improved compared to pre-test scores, the effect was small and the mean post-test scores still 
reflected negative attitudes towards people with substance addiction. The written reflections of 
the students following the intervention further demonstrated that this sample continued to 
harbour stigmatizing views towards the drug using population. Crapanzano et al. (2014) 
concluded that the persistence of negative attitudes towards people who use drugs following this 
and other educational interventions indicates the need for a new approach to changing stigma 
towards this population. Overall, while there have been steps taken towards reducing the 
stigmatization of those with substance addiction in Canada and elsewhere, there has been 
minimal research that suggests these strategies were successful.  
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Chapter 7: Recommendations 
Four recommendations were devised from the themes that emerged from the current 
research. The themes discussed and analyzed were the support from participants to: (1) 
decriminalize all illicit substances and implement a medical model approach; (2) legalize specific 
substances through a prescribed safe supply; (3) increase treatment program availability and 
affordability, along with holistic and individualized care practices; and (4) increase Canadian 
society’s awareness and knowledge of substance addiction to aid in reducing stigmatization. 
From these four themes, recommendations were made.  
Where there is a Will, there is a Way: The Push for Decriminalization 
In response to the support for decriminalization among the participants, this option was 
further explored. After reviewing the relevant literature on this practice, it is evident that 
decriminalization may be a viable option to reduce the harms associated with substance use and 
addiction. Due to Canadian drug policy following social and political trends rather than 
evidence-based practices, this option may be avoided by the Federal Government. Therefore, 
action is needed to assess the effectiveness and efficiency of this model in Canada – to provide a 
comprehensive argument for the implementation of this approach.  
Given that there are several models of decriminalization worldwide, further research on 
the effectiveness and efficiency of these models is needed. As Portugal’s policy on drug 
decriminalization may be viewed by many as a best-practice model, it is recommended that 
future research explore the feasibility of implementing this model in Canada. To accomplish this, 
a transferability assessment is needed to determine if this model could be successfully 
implemented in Canada. This assessment will need to consider the specific cultural and 
governmental differences between Portugal and Canada, as these differences may affect the 
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transferability of this model. Additionally, a cost-benefit analysis will need to be conducted. The 
findings from this research will aid in distinguishing the possible effectiveness and efficiency of 
this model in Canada.   
Safety is First: Exploring Regulatory Options 
As with all major drug law reforms, there will need to be evidence that the model will be 
both effective and efficient in achieving its intended goals for the approach to be endorsed by the 
government. Moreover, there needs to be both political and social support. Clearly, there is a 
need for a safe supply of substances in Canada, as people continue to die from drug-related over-
doses. Substances obtained through the illicit drug market are clearly not safe for consumption, 
and the refusal to provide safe alternatives is contributing to the current opioid overdose 
epidemic. Hence, the following recommendations were made to address this growing issue.  
The Federal and Provincial Governments should continue to explore the possibility of 
legalizing and regulating a safe supply of drugs to those who are suffering from substance 
addiction. Further Canadian-based research is needed to explore the effectiveness and efficiency 
of this drug policy reform. Both the benefits and weaknesses will need to be considered, along 
with the feasibility of this reform. Moreover, research on the recent legalization of cannabis may 
serve to enlighten the future of this option – since these studies will have assessed the short-term 
outcomes of cannabis legalization in this jurisdiction.  
Possible regulatory options will need to be assessed and collaboration with provincial 
medical and mental health systems will be critical. Moreover, research on the effects of this 
policy change on the criminal justice system will be essential. Overall, it is recommended that 
research be implemented in the Canadian context to explore the possibility of a safe supply of 
drugs.  
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Modernized Substance Addiction Treatment: We Are Not all the Same 
Federal and Provincial Governments must recognize the need for more available and 
affordable treatment options that encompass an individualized and modern approach to substance 
addictions. In other words, alternatives to traditional treatment options need to be developed and 
implemented to allow more individuals success in recovering from this illness. To realize this 
goal, the Federal and Provincial Governments must increase their support for and funding of 
both traditional and non-traditional treatment alternatives – with the aim of increasing program 
capacity and reducing costs to patients. These governments must recognize that traditional 
addictions treatment does not work for all individuals experiencing substance addiction; 
therefore, research and comprehensive program evaluations need to be conducted on both 
existing treatment programs and innovative and modern programs to evaluate their effectiveness 
and efficiency in treating substance addiction.  
Moving forward, all treatment programs need to recognize the lived experiences and 
differences between each individual seeking recovery and allow for non-traditional methods of 
recovery, such as partnering opioid agonist therapy and other harm reduction strategies with 
treatment. Essentially, traditional abstinence-based treatment programs are not beneficial to all 
individuals; hence, an innovative and individualized program model that is based on science and 
evidence-based practices needs to be developed and implemented. This would result in an 
increase of successful recoveries from substance addiction. 
Ending Stigmatization through Awareness and Knowledge 
The stigmatization of people who use drugs is inherently linked to entrenched social 
values and public morality; therefore, a multiple faceted strategy is needed to reduce the 
stigmatization and discrimination of this population. PSAs and educational training alone will 
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not end the stigmatization of this population, yet these strategies may increase knowledge on 
substance addiction and normalize this disease. The Federal and Provincial Governments should 
continue to promote positive messages about those with substance addiction. In addition, 
education on substance addiction needs to be offered to individuals at all academic levels – and 
included in school curriculums.  
Apart from education, acknowledging the lived experiences and knowledge of those who 
have experienced drug use and addiction is a positive step to reducing the stigma against this 
population. Essentially, allowing the voices of this population to be heard may reduce the 
entrenched stigmatization of those with substance addiction. Lastly, further analysis of this issue 
needs to be conducted in Canada to understand its extent in the Canadian context. Findings from 
this research will aid in developing and implementing a new approach to changing the current 
stigma towards people who use drugs.  
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Chapter 8: Limitations 
Sample Size, Composition and Technique  
While this study has yielded several important findings regarding the perceptions of those 
who have experienced substance addiction on Canadian drug policy, there are some limitations. 
The first limitation concerns the small sample size from which this research was generated. 
While the researcher exhausted their options for recruiting, there were a total of 19 participants. 
Due to the qualitative and exploratory nature of this study, this sample size is considered 
adequate; however, statistical analysis was limited and generalizations about this populations’ 
perceptions on Canadian drug policy cannot be inferred. This limits the ability to generalize the 
findings to a Canadian wide context. Future research in this area would benefit from recruiting 
larger numbers of participants or conducting both focus groups and one-on-one interviews.  
A second limitation is that a majority of the participants in the sample resided in the 
interior and coastal regions of BC, while only one participant lived in the northern region.28 
Thus, the study covered a large geographical region; however, it was limited to the province of 
BC. Additionally, many of the participants resided in urban areas during their addiction, lending 
a limited perspective of those who live in rural Canada. Given that Canada is a large country and 
perceptions on drug policy may vary across provinces and between rural and urban areas, this 
may have impacted the results of the study. Moreover, there are unique differences between the 
west coast, central prairies, east coast, and maritime regions, which further decreases the 
generalizability of the findings.  
                                                 
28 Some of the participants disclosed that they had resided in the Downtown Eastside of Vancouver during their 
substance addiction, while others reported to have lived in cities such as Kelowna, Penticton, and Prince George. 
Other participants lived throughout the Lower Mainland, and one reported he had spent some time in Alberta. 
Nonetheless, all of the participants of the study resided in BC during the interviews.  
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Future research would benefit from recruiting participants from across Canada. Another 
option would be to conduct similar studies in specific locations across Canada to compare and 
contrast the findings to the current study in BC. These studies would elicit the perceptions of 
those who have experienced substance addiction across the entire country.  
A third limitation concerns the sampling technique. Due to the potential difficulties in 
recruiting persons who had experienced or were currently experiencing substance addiction, the 
snowball sampling technique was used. This is a non-probability sampling technique, which is 
based on the subjective judgement of the researcher, rather than random selection. This sampling 
technique does not allow for generalizations to be made, due to its non-probability nature. 
Moreover, a snowball sample allows for sampling bias, as the initial subjects tend to nominate 
people they know well. Thus, the participants in the sample may have been from similar peer 
groups and have similar ideologies. This may be why a majority of the sample had attended 
abstinence-based treatment, counselling, or NA and AA programs. Similar participant biases and 
ideologies could have skewed the findings of the research. Therefore, future research in this area 
should consider other sampling techniques.  
Overall, limitations within this research were found within the sample size, geographical 
composition, and recruitment technique. As a result of these limitations, caution should be used 
in making generalizations on the findings of the current study. Nonetheless, despite these 
sampling shortcomings, the findings from the current exploratory research are valuable insights 
into the perceptions of those who have experienced addiction.  
Limited Perspectives 
Two other limitations in this study are worth noting in more detail. The first concerns the 
gender composition of the sample. Due to the snowball sampling technique, there was not an 
 108 
equal or representative number of male and female participants. Thus, 15 of the participants were 
male while only four participants were female. Given that men and women have different 
experiences with their substance addictions and personal histories, the distribution of gender in 
this sample may have affected the findings (Neale, 1998). Future research in this area would 
benefit from utilizing a probability sampling technique or a non-probability sampling technique 
that allows for representative gender groups.  
The second limitation relates to the proportion of the sample that had been sober from 
illicit substances for longer than 90 days compared to those who were still actively using. Of the 
19 participants, only three had used illicit substances within 90 days of the interviews. The 
perceptions of those who had successfully recovered from their addiction could have been 
significantly different from the perceptions of those who were still active. Thus, the findings may 
have been affected by the limited number of perspectives.  
In that regard, future research in this area would benefit from studying the effects of 
successful recovery from an addiction on the perceptions of Canadian drug policy. It would be 
interesting to note if there were differences between those who had recovered from their 
addiction and those who were still actively using. Essentially, while these limitations exist, the 
findings still provide valuable insight into how people who have experienced addiction perceive 
Canadian drug policy.  
Inter-Rater Reliability  
 The analysis of the findings was an iterative process that was completed by the researcher 
alone. This is a limitation to the data analysis process, due to the lack of inter-rater reliability. As 
such, the biases and personal assumptions of the researcher, as someone who has never 
experienced addiction and who is employed by the criminal justice system, could have affected 
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the understanding of the content. Thus, future research should incorporate multiple reviewers of 
the data to ensure inter-rater reliability.  
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Chapter 9: Conclusion 
In Canada in recent years, thousands of people have died due to illicit drug overdoses 
caused by increasingly powerful and contaminated substances offered through the illicit drug 
market (Corace et al., 2019). The current drug-related overdose crisis has presented an 
opportunity for drug policy changes throughout Canada. Canadian drug policy has been largely 
based on social and political factors, rather than on scientific research and ‘evidence-based’ 
practices (Malleck, 2015). This led to over a century of prohibitionist policy that had an array of 
adverse outcomes, including high drug overdose rates, high rates of infectious diseases caused by 
needle-sharing, high rates of incarceration for drug offences, expensive law enforcement costs, 
and no significant reductions in drug use (Hathaway & Tousaw, 2008). However, the current 
Canadian Government has taken steps to reform Canadian drug policy and legislation. To date, 
they have implemented several progressive policies on drug possession and use and have funded 
and supported multiple harm reduction initiatives.  
While these initiatives have been effective in reducing various drug-related harms, 
including fatal overdoses, the rates of drug-related overdose deaths have continued to increase 
each year (Government of Canada, 2018c; Irvine et al., 2019; Kennedy et al., 2019). 
Additionally, some have argued that while drugs remain illegal, people who use drugs will 
continue to be marginalized from society and further criminalized, which decreases the overall 
effectiveness of the harm reduction strategies implemented (van der Meulen, De Shalit & Ka 
Hon Chu, 2018; Lavalley, Kastor, Valleriani, & McNeil, 2018). These arguments and the 
continuance of drug-related deaths have fuelled support for increasingly liberal drug policy in 
Canada, including discussions on decriminalizing all illicit drugs and providing safe supplies for 
people who use opioids (Angus Reid Institute, 2019; Corace et al., 2019). Therefore, it was clear 
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that further research on effective and efficient drug policy was warranted to combat the growing 
concerns related to the harms associated with drug use and substance addiction. 
To inform future drug policy changes in Canada, several key groups of stakeholders 
should be involved. In particular, the perceptions of people who have experienced addiction 
should be considered. This includes recognizing the lived experiences of individuals who use 
drugs and considering their opinions of the current legislation and subsequent strategies 
employed by the government to reduce the use of drugs, decrease the harms associated with drug 
use, and prevent and treat substance addiction.  
The research was designed to further the understanding of how those who have 
experienced substance addiction view the current and past drug policies in Canada and what they 
believe are effective and ineffective drug strategies within the system. The findings of this 
research add to the growing body of literature that considers the perspectives of those who are 
addicted to illicit substances – a population that is arguably the most affected by drug policy. 
In addition to gaining the insight of those who have experienced substance addiction on 
Canadian drug policy, the current study explored the history of Canadian drug policy to better 
understand the effects on individuals with substance addictions. Moreover, the current study was 
successful in investigating how changes in government mandate on drug policy affects those 
who are struggling with substance addictions. In doing so, the research found and analyzed the 
perceived effects of punitive versus rehabilitative approaches to preventing and treating 
substance addictions. Lastly, the research was successful in investigating potential options for 
future drug policy changes that are supported by those who have experienced or are currently 
experiencing substance addictions. These options were further analyzed and discussed in Chapter 
6.  
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Four key themes emerged from this data. The first theme was the support among 
participants for illicit substances to be decriminalized in Canada, while the second theme was the 
support for a legalized safe supply of these substances. Both of these legal reforms were largely 
supported by the participants, whose goals were not to allow free reign on drug use, but to 
implement a system that could regulate or better monitor and address problematic drug use. The 
participants recognized the current harms of drug prohibition on people who use drugs and 
offered plausible solutions to the current overdose epidemic.  
The following two themes considered strategies and programs, rather than laws. The third 
theme was the desire for more affordable and available treatment programs, and the need for 
these programs to be more holistic in nature. Essentially, the participants argued that a one-size-
fits-all approach to recovery was not an ideal strategy. The final theme emerged reflected the 
need to reduce the stigmatization of those who use drugs. This was viewed as an important and 
critical finding, since the research questions did not ask about nor mention stigmatization. Thus, 
this theme emerged entirely on its own, without prompting.  
The participants explained their experiences of being stigmatized and noted the barriers 
that this stigma creates. It was concluded that the stigmatized perception of those who use drugs 
in Canadian society has decreased the perceived value of their knowledge and lived experiences 
that could help to inform drug policy. Additionally, it was argued that the continued 
discrimination of this population has exiled them from serious consideration of having a stake in 
policy development. Nonetheless, it is maintained that acknowledging the lived experiences and 
knowledge of those who have experienced drug use and addiction is the first step to reducing the 
stigma against this population. 
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Overall, the research findings are an important addition to the growing body of literature 
that considers the knowledge and lived experiences of those who have experienced drug use and 
substance addiction. The current research was exploratory in nature and was successful in 
achieving its goals and objectives. While the findings cannot be generalized to all people who 
have experienced addiction or have used drugs, they should be considered in future studies and 
policy development. Research in this area must include this population in discussions on drug 
policy, as they are one of the central stakeholder groups and arguably the most affected by drug 
policy reform. Essentially, progressive and inclusive research and policy development should 
continue to emerge with the start of the new decade, because, as one participant stated, “The 
drug is not the problem, the problem is that we have stigmatization along with using drugs” – a 
fact to which Canadian policies, laws, and strategies need to recognize (AJ).  
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Appendix A – Interview Guide 
 
Demographic questions:  
What is your age? 
What gender do you identify as? 
What level of education have you achieved? 
Are you employed? If so, in what occupation? 
Approximately how many years were you/have you been dependent on a substance, and what 
were the years? 
What was/is the substance you used/use, and what method of consumption? 
Approximately, when was the last time you used? 
Are you currently seeking treatment for a substance addiction or using any harm reduction 
measures? 
General open-ended questions:  
1. What are your overall views on Canadian drug policy?  
a. What are your views on the recent legalization of cannabis? Do you feel that other 
drugs should be legalized or decriminalized? 
b. What are your views on harm reduction measures? Treatment programs? 
2. Have you felt that the approaches taken towards substance addictions has changed in 
Canada over time? If so, do you agree with these changes? 
3. In your experience, are tough-on-crime approaches beneficial or harmful to someone 
experiencing a substance addiction? 
4. In your experience, are harm reduction approaches beneficial or harmful to someone 
experiencing a substance addiction?  
5. What would you like to see be done in Canada in regard to drug legislation?  
6. What would an ideal approach to drug use and addiction be?  
7. In your opinion, what current approach to substance addiction is the least effective for 
those struggling with addictions?  
8. In your opinion, what current approach to substance addiction is the most effective for 
those struggling with addictions? 
Word Prompts: 
- Legalization 
- Decriminalization 
- Prohibition 
- Tough-on-crime 
- Harm reduction 
- ‘soft’ drugs versus ‘hard’ drugs 
- Insite/Supervised Injection Sites 
- Naloxone Programs 
- Treatment Programs  
- Mandatory Minimum Sentencing 
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Appendix B - Certificate of Human Research Ethics Board Approval 
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Appendix C – Informed Consent and Consent of Participation Forms 
 
School of Criminology and Criminal Justice 
University of the Fraser Valley 
33844 King Road 
Abbotsford, BC V2S 7M8 
604-504-7441 
 
The Perceptions of those who have Experienced Substance Addiction on Canadian Drug 
Policy 
Letter of Informed Consent 
Purpose of the Study: I, Meghan Jansons, am a graduate student, in the School of Criminology 
and Criminal Justice at the University of the Fraser Valley, conducting research for my final 
thesis project. During this interview, I am hoping to learn the opinions and views of those who 
have experienced substance addiction on Canadian drug legislation and strategies.   
Procedures involved in the Research: This research project will involve a one-on-one 
interview that will take approximately 30 minutes to complete. The interviewer will be taking 
notes during the interview, and with your permission, the interview will be audio recorded and 
later transcribed verbatim for accurate data collection. If you would like to review the transcript 
from your interview, a copy can be sent to you upon its completion via email. In this interview, 
you will be asked questions about your views on and experiences with Canadian drug policy 
specifically regarding drug laws and various treatment and harm reduction programs.  
Potential Benefits: The time that you have devoted to participating in this research will be 
compensated with a $10 CAD Tim Horton’s gift card. While the research will not benefit you 
directly, the results will add to the academic literature on this topic and may help to inform the 
creation and/or implementation of consumer-informed drug policy and strategies in Canada.  
Potential Harms, Risks or Discomforts to Participants: This study will not use deceptive 
tactics, or intend to cause any physical, psychological, or social harm. However, some discussion 
topics may require you to recall difficult or sensitive memories, which may be mentally and 
emotionally strenuous. You may refuse to answer any questions that make you feel 
uncomfortable, or that you wish not to answer. Additionally, the information to access a 
counsellor is provided below for participants who require additional support or debriefing. 
Fraser Valley Regional Crisis Line (24hrs): 604-820-1166 or 1-877-820-7444 
Interior Crisis Line Network (24hrs): 1-888-353-2273 
Confidentiality: Any information that is obtained during this study will remain confidential. 
Only the primary investigator, Meghan Jansons, will have access to your interview responses, 
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which will be stored on a password protected computer. The data will be included in my thesis 
paper and presented during my thesis presentation; however, pseudonyms will be used to protect 
the participants’ identities and no identifying characteristics will be displayed in the paper or 
presentation. All identifying documents pertaining to the interviews will be destroyed after the 
research is completed, on June 1, 2020 (i.e., interview transcripts will be shredded, and all audio 
and text files will be deleted). 
Participation: Your participation in this study is voluntary. You may withdraw your consent and 
discontinue participation at any time during the study. You may also decline to answer specific 
questions during the interview yet remain in the study, if you so choose. There are no penalties 
for declining to participate or withdrawing your participation. If you withdraw from the study, 
your data will not be used, and your interview record will be destroyed immediately. If you 
choose to withdraw from the study during the interview, please inform the interviewer. If you 
decide to withdraw from the study after the interview, please contact me at 
meghan.jansons@student.ufv.ca. 
Study Results: The results of this study will be disseminated by myself through my thesis paper. 
The research may also be made public in future conference presentations or a research paper. If 
you would like to know the research findings, a copy of my final written work can be sent via 
email upon request once it is completed. Please email me at meghan.jansons@student.ufv.ca if 
you are interested.  
Questions: 
Contact for Information About the Study  
For any questions relating to the study, please contact me, Meghan Jansons, at 
meghan.jansons@student.ufv.ca.  
Contact for Concerns 
If you have any questions or concerns regarding your rights or welfare as a participant in this 
research study, please contact the Ethics Officer at 604-557-4011 or Research.Ethics@ufv.ca.  
The ethics of this research project have been reviewed and approved by the UFV Human 
Research Ethics Board (Protocol #1163C-19, approved June 5, 2019). Please feel to ask any 
questions you may have about these procedures or the research study. You may also keep a copy 
of this form for your records. Thank you for your time and interest.  
I have read the above and understand the procedures, risks, and benefits of this study. By 
participating in this interview, I am consenting to participate in this study.  
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The Perceptions of those who have Experienced Substance Addiction on Canadian Drug 
Policy  
Consent of Participation Form 
 
By signing below, I agree to participate in this study, titled the Perceptions of those who have 
Experienced Substance Addiction on Canadian Drug Policy.  
 
I have read the information presented in the letter of informed consent being conducted by 
Meghan Jansons at the University of the Fraser Valley. I have had the opportunity to ask 
questions about my involvement in this study and to receive any additional details. 
 
I understand that I have the right to withdraw from the study at any time and that confidentiality 
of all results will be preserved. If I have any questions about the study, I should contact Meghan 
Jansons at meghan.jansons@student.ufv.ca.   
 
If I have any concerns regarding my rights or welfare as a participant in this research study, I can 
contact the UFV Ethics Officer at 604-557-4011 or Research.Ethics@ufv.ca.  
 
By checking the box below, I consent to being audio recorded during the interview. 
 
Note: You may still participate in the study if you do not consent to being audio recorded.  
 
Name (please print)  ____________________________________________________________  
Signature  ____________________________________________________________________  
Date  ________________________________________________________________________  
Name of Witness (please print) ____________________________________________________ 
Witness Signature ______________________________________________________________ 
Once signed, a copy of this consent form will be provided to you. 
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